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ancient god Horus is considered a symbol of health.
2The Burroughs Wellcome Fund is an independent private foundation dedicated to
advancing the medical sciences by supporting research and other scientific and 
educational activities. Within this broad mission, we seek to accomplish two primary
goals—to help scientists early in their careers develop as independent investigators,
and to advance fields in the basic medical sciences that are undervalued or in need 
of particular encouragement.
BWF has an endowment of about $600 million, and we award approximately 
$35 million in grants annually in the United States and Canada. We channel our financial
support primarily through competitive peer-reviewed award programs, which encompass
five major categories—basic biomedical sciences, infectious diseases, interfaces in science,
translational research, and science education. BWF makes grants primarily to degree-
granting institutions on behalf of individual researchers, who must be nominated by
their institutions. To complement these competitive award programs, we also make
grants to nonprofit organizations conducting activities intended to improve the general
environment for science.
The Burroughs Wellcome Fund was founded in 1955 as the corporate foundation
of Burroughs Wellcome Co., the U.S. branch of the Wellcome pharmaceutical enterprise,
based in the United Kingdom. The Wellcome enterprise was started in 1880 by two
young American pharmacists, Henry Wellcome and Silas Burroughs, who had moved
to London to manufacture and sell “compressed medicines”—that is, pills—which the
pair believed could replace the potions and powders of the day.
Their firm prospered. After Silas Burroughs died in 1895, Henry Wellcome directed
the growth of the company into an international network with subsidiaries in numerous
countries on several continents. As the business grew, Henry Wellcome held firm to his
strong belief that research was fundamental to the development of excellent pharmaceutical
products—a belief he put into practice by establishing the industry’s first research 
laboratories.
When Henry Wellcome died in 1936, his will vested all of the corporate shares in
a new organization—the Wellcome Trust—devoted to supporting research in medicine
and allied sciences and to maintaining museums and libraries dedicated to these fields.
Over the decades, the Trust grew to become the world’s largest charitable foundation
devoted exclusively to the biomedical sciences.
In 1955, leaders at the Wellcome Trust and Burroughs Wellcome Co.-USA envisioned
an extension of this effort in the United States—and so was born the Burroughs Wellcome
Fund. After nearly four decades as a corporate foundation, BWF in 1993 received from
the Trust a $400 million gift that enabled us to become a completely independent
foundation. With this increase in assets, BWF has been able to play a larger role in
funding biomedical research, including extending our support into Canada. In carrying
out this work, BWF is governed by a Board of Directors composed of distinguished
scientists and business leaders, and our competitive award programs are guided by
advisory committees composed of leading researchers and educators.
The importance of curiosity-driven research, as endorsed by Henry Wellcome, 
continues as our guide. Thus, more than a century after two enterprising American
pharmacists set in motion their pioneering partnership, the Burroughs Wellcome 
Fund remains committed to the belief that fostering research by the best and brightest
scientists offers the fullest promise for improving human health.
ABOUT THE BURROUGHS WELLCOME FUND
The year 2001 was one of transition and reflection for the Burroughs Wellcome Fund.
As the Fund began the process of implementing the restructured programs that resulted
from our evaluation in 2000, we reflected on the accomplishments of our long-standing
programs and reaffirmed the core principles that provide our distinctive mark as a
foundation dedicated to advancing the medical sciences:
• By providing biomedical scientists support that bridges the postdoctoral and early
faculty years, BWF fills an unmet need for “risk capital” at a transition point
when traditional funding generally is not available. Such funding gives scientists
the freedom and flexibility to choose their own research directions and provides
them with a stable source of funding while they demonstrate the promise of those
new directions to prospective employers and funding agencies. This approach has
been shown to have a tremendous impact on the career development of scientists
early in their careers. As part of our restructuring, we have made certain that all
our programs contain a career development component. 
• BWF can help accelerate the development of new directions in science by supporting
scientists early in their careers and providing these young scientific leaders with
seed capital just as a new field is beginning to emerge. In this way, BWF can have
an impact on their individual career development as well as help propel emerging
science, particularly in scientific areas that are undervalued or in need of 
encouragement. 
By focusing on these core principles, the Fund is able to leverage our grant dollars
and fill a unique niche: opening doors to new areas of research that are considered too
risky for public funding agencies. 
Such has been our role from the beginning of our 46-year history. Our programs 
in pharmacology and toxicology reflected both our roots in the pharmaceutical industry
and our desire to help build an academic infrastructure for study of the effects of thera-
peutic drugs and toxic substances in people. As these were nascent fields only 20 years
ago, it was with great pleasure that we reflected on the growth and maturation of the
pharmacological and toxicological sciences since the Fund first began targeted support
to nurture them in their early days. 
Now firmly ensconced as distinct scientific disciplines, both pharmacology and
toxicology are poised to take full advantage of the dramatic advances in genomic science
that are rapidly changing the biomedical research landscape. Our Innovation Awards 
in Functional Genomics, awarded in 2000, provide nearly $3 million for research that
defines the functions of genes and shows how genes interact within the context of the
whole organism. We made 11 awards to scientists or teams of scientists in the United
States and Canada to help jump-start the emerging field and encourage novel approaches
that have the potential for high impact but might not have been funded through traditional
means. These special commemorative awards will not be offered again. However, we
recognize that genomic approaches will soon permeate science, and we hope to see
proposals that incorporate genomics in our ongoing award programs.
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REPORT FROM THE PRESIDENT: 
Building on the Past, Investing in the Future
By Enriqueta C. Bond, Ph.D.
Science Education 
$1.45 million (4 percent)
Infectious Diseases 
$4.2 million (10.5 percent)
Interfaces in Science 
$11.7 million (29 percent)
Basic Biomedical Sciences
$12.2 million (31 percent)
Translational Research 
$10 million (25 percent)
Science and Philanthropy 
$0.2 million (0.5 percent)
BWF GRANTS APPROVED IN 
FISCAL 2001, BY FOCUS AREA
TOTAL = $39.8 MILLION
BWF has likewise responded to the emerging opportunities afforded by advancements
in interdisciplinary work that combines the physical, computational, and biological 
sciences. Our Institutional Awards at the Scientific Interface (see grants awarded on p. 41)
are helping train the next generation of scientists who will develop novel imaging tools
or biosensors, apply nanotechnology to manipulate cellular systems, and apply genomic
information to drug development. Since 1996, this program has made 10 awards to
colleges and universities that are creating the prototypes for a new kind of graduate and
postdoctoral training, one that crosses departmental boundaries and provides much-needed
bridges among scientific disciplines.
We enjoyed seeing our investments in the field of malaria research come to fruition
in 2001, as scientists agreed that the genome sequence of the malaria parasite, Plasmodium
falciparum, is complete enough to warrant publication of the data, which is expected in
2002. The BWF-supported PlasmoDB, the malaria sequencing project database, continues
to make this resource accessible to researchers who want to access the genomic information.
PlasmoDB now includes a database of scientific papers focused on Plasmodium. Tools
for access to data, including an improved search function, have been installed. A text-
searchable database comprising all genes found in the Plasmodium sequence also makes
it easier for bench scientists to use PlasmoDB and to immediately find genes of interest.
A truly international resource, PlasmoDB has already been visited by researchers from
more than 60 countries.
While 2001 marked the last year of support for BWF’s New Initiatives in Malaria
Research Awards, Scholar Awards and New Investigator Awards in Molecular Parasitology,
and Scholar Awards and New Investigator Awards in Molecular Pathogenic Mycology,
once again our focus is toward the future. Our new program, Investigators in Pathogenesis
of Infectious Disease, will encompass our historical interest in supporting underfunded
areas of science and our desire to help jump-start promising new avenues of research
in host-pathogen interactions (see article on p. 7 for more details).
The ongoing Wellcome Trust-Burroughs Wellcome Fund Infectious Diseases Initiative
made six awards in 2001 for a total investment of $6 million in global collaborative
research projects in tropical infectious diseases. Launched in 1998, the initiative was
established to support trilateral international collaborations among researchers in the
United States, the United Kingdom, and developing countries. 
Three of the six funded projects propose to study human parasitic worms, another
will target drug-resistant tuberculosis, and the others will focus on the role of infectious
agents in common intestinal and diarrheal diseases in children. A significant component
of the selection process was a demonstrated commitment by the investigators to train
scientists on-site in the developing country, increasing the research capacity of scientists
in the countries most affected by tropical infectious diseases.
BWF has always believed that to maintain the strength of the biomedical research
enterprise, we must build for the future by investing in people. Our longtime board
members Drs. George Hitchings and Gertrude Elion, who shared the Nobel Prize in
Physiology or Medicine in 1988, maintained that a small amount of money given at the
right time to young researchers can have a catalytic effect on their scientific productivity
and their careers. 
In 2001, we announced Career Awards in the Biomedical Sciences to universities to
support 23 women and men who will be among the next generation of scientists to chart
the course to a healthier nation and world. Entering its seventh year in 2002, this career
awards program has established a reputation for helping scientists early in their careers
develop as independent academic research scientists. Our philosophy is that we are
funding a person, not just a project. To support this philosophy, BWF’s commitment to
fostering the careers of our awardees extends well beyond the grant support provided.
Report from the President
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In talking to our awardees, we have found that many are lacking key information
about how to handle critical issues as their careers progress. By convening awardees—as we
did at our summer 2001 career awards meeting at our headquarters in Research Triangle
Park, North Carolina, and our new investigators meeting in Coronado, California—we
provide an opportunity to build a network of professional connections that can provide
support, advice, and scientific collaborations. In addition, our convocations have as an
integral component career sessions, developed with the advice of our awardees, that focus
on topics such as negotiating a faculty position, managing a laboratory, setting up a
collaboration with another research group, or working with industry.
We have found that career support is critical, in particular, for physician-scientists,
given their many clinical obligations that create a real test of commitment to find time
for basic or clinical research. The continued decline in the number of physicians who
list research as their primary career has prompted several private biomedical research
funders, including the Burroughs Wellcome Fund, to seek new avenues, beyond providing
grant dollars, to support the clinical research enterprise. In 2001, we redoubled our
efforts to support clinical investigators through several venues. We supported Clinical
Research 2001, the first joint meeting of the American Federation for Medical Research,
the General Clinical Research Center Directors’ Association, and the Association for
Patient-Oriented Research. We brought together a group of five foundations to provide
collaborative support for this meeting. 
The Fund also organized, in collaboration with the Juvenile Diabetes Research
Foundation International, an informal association of 11 private foundations that have 
a common interest in strengthening the career development opportunities for physicians
interested in pursuing patient-oriented research. We believe that an important role for
foundations is to make clear the importance of maintaining both private and public
financial support for the career development of patient-oriented researchers. One of the
group’s first actions was to gather data on the level of commitment made by private funders
to the training of clinical investigators in the past five years. That data, shown in the
table on page 6, indicated that the level of investment of private foundations in young
clinical investigators had tripled since 1997. This information prompted the group to
ask the federal funding agencies to provide another critical incentive for new clinical
investigators: repayment of their medical school loans. 
In addition, I am serving as cochair of the Institute of Medicine’s Clinical Research
Roundtable, which provides a forum and sponsors workshops for discussion of approaches
to resolution of both acute and long-term issues affecting clinical research. Two of the
key issues the Roundtable has addressed include: the ability of academic health centers
to conduct clinical research and training and the timely incorporation of new research
findings into clinical practice.
Just as we have been shaping our role in the biomedical research arena, we have
also been increasing our involvement in science education in our home state of North
Carolina. Engaging students in hands-on science inquiry has been the primary focus 
of the BWF science education program since the Fund became an independent private
foundation in 1994. During this period, the state has made clear improvements in K-12
education. Yet more can be done, and a number of educational advisers who work with
the Fund have pointed to the need for a science, mathematics, and technology champion
in North Carolina. In recognition of the neutral role we can play as a convener and 
galvanizer of people toward a common goal, we took the first steps toward establishing
a new organization, which will be a separate, distinct nonprofit entity from the Fund. Its
mission will be to improve K-12 performance in science, mathematics, and technology
as a means of providing all children in North Carolina with the skills to have successful
careers, be good citizens, and advance the economy of the state.
Report from the President
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Collective Investment of 11 Private Organizations2 in the Training and
Career Development of Physician-Scientists in Clinical Research1
Number of Total number Annual Total financial
new awards of individuals financial commitment
made supported commitment 1997-2001
CAREER LEVEL annually 1997-2001 (in millions) (in millions)
Medical Students
Prior to 1997 100 $ 3.4
Since 1997 43 $ 1.5
Subtotal 143 530 $ 4.9 $ 18.9
Fellows and Residents 
Prior to 1997 153 $ 20.1
Since 1997 5 $ 3.0   
Subtotal 158 574 $ 23.1 $ 64.1 
New Investigators 
Prior to 1997 61 $ 9.5   
Since 1997 92 $ 20.2   
Subtotal 153 361 $ 29.7 $ 82.6     
Mid-Career Investigators 
Prior to 1997 10 $ 4.0   
Since 1997 20 $ 16.8   
Subtotal 30 113 $ 20.8 $ 79.1
TOTALS 484 1578 $ 78.5 $ 244.7 
1 Organization staff provided data on support for clinical research award programs at 
each career level. Programs shown include only those that are considered responsive 
to the CRP definition of “clinical research,” and do not include all of the programs in 
the organizations’ portfolios. Data considered accurate as of July 12, 2001.
2 Participating organizations include: American Cancer Society, American Diabetes Association,
American Heart Association, Arthritis Foundation, Burroughs Wellcome Fund, Damon
Runyon-Walter Winchell Cancer Research Fund, Doris Duke Charitable Foundation,
Howard Hughes Medical Institute, Juvenile Diabetes Research Foundation International,
Leukemia and Lymphoma Society, and Robert Wood Johnson Foundation.
Report from the President
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As we look forward to 2002, we will be moving toward a steady state in our grant
programs, thereby reaching a more mature phase of our development as an organization.
In addition, our endowment was reduced slightly by the worldwide economic downturn
in 2001. This overall leveling off means that our staff will be refocusing their efforts
toward broadening the range of support we offer our existing awardees. In addition, we
will be evaluating the effectiveness of our grants to ensure we are making the best use
of limited grant dollars. We will be looking forward to the opportunity to having a more
open dialogue with our awardees, to learn of their struggles and accomplishments, and
to seek new ways to help them succeed. By learning from those who are on the front
lines in biomedical research, we can then help pave the way for laboratory and clinical
advances that will ultimately improve human health and the quality of our lives.
7Sir Henry Wellcome, who cofounded the pharmaceutical enterprise that ultimately gave
rise to the Burroughs Wellcome Fund, had a passionate interest in the infectious diseases,
especially those of the tropics. He acted on it. His concern with easing human suffering
led him to finance laboratories in Africa and Great Britain dedicated to the study of
tropical infectious diseases. Building on Sir Henry’s interests, BWF has long focused
significant resources on understanding the inner workings of the organisms that infect
humans. So far, the Fund has invested more than $20 million in this critical research area.
From the mid-1950s through the 1960s, BWF provided grants to the American
Foundation for Tropical Medicine to support research at the Liberian Institute, in Harbel,
Liberia, West Africa. These grants were targeted toward achieving a better understanding
of river blindness, a debilitating disease that today is well controlled. Other BWF grants
supported the institute’s work on malaria, schistosomiasis, trypanosomiasis, and filariasis.
In the same period, BWF supported training for medical students in pathology and
parasitology, providing opportunities for them to study parasitic diseases in the Caribbean,
Africa, India, South America, and Taiwan. BWF also supported, later in our history,
programs to bring medical care to regions where tropical diseases are endemic. At the
same time, we sponsored externally managed programs including the Burroughs Wellcome
Fund Fellowships in Infectious Diseases, which supported young physicians, and the New
Investigator in Virology awards, which supported basic research by assistant professors.
This work, like much of the historical work on the infectious diseases, was largely
phenomenological—that is, describing the nature of diseases rather than exploring 
specific biological questions. The molecular biology revolution of the late 1970s changed
research in infectious diseases, enabling scientists to understand at the molecular level
how disease-causing processes work.
As we entered the 1980s, the Fund evaluated progress in molecular approaches to
research and decided to ramp up our investment in infectious diseases research. Studies
of the difficult to manipulate eukaryote pathogens—the parasites and fungi—lagged
behind work in the more easily propagated bacteria and viruses. The slow start of molecular
biology in the parasites was especially troubling, since parasitic infections such as malaria,
leishmaniasis, and Chagas’ disease—all of them disproportionately infecting poorer geo-
graphic regions—are among the world’s most deadly and debilitating diseases. For this
reason, the Fund’s internally managed infectious diseases program, launched in 1981,
was fully focused on one thing: attracting visionary researchers with excellent skills to
bring the then-new molecular biology to the study of the tropical diseases that had so
moved Henry Wellcome when he witnessed their human toll. At launch, the BWF
Scholar Awards in Molecular Parasitology program supported senior researchers with
five-year grants of $250,000—nearly $500,000 in 2001 dollars. 
TAKING A LONGER VIEW: 
Reorienting the Fund’s Investments in Infectious Diseases
By Victoria McGovern, Ph.D., program officer for infectious diseases
Taking a Longer View
Twenty years later, a new revolution is dramatically changing science’s capacity 
to understand how disease works. In 2001, the sequencing of the human genome was
completed, bringing researchers much closer to reading the rules by which our bodies
operate. But scientists still are far from understanding these rules. Genomic sequencing
and the approaches to understanding gene function that derive from it are changing how
science approaches questions central to understanding sickness and health. It is becoming
possible to study the whole of human health in ways not dreamed of even a decade ago.
Over the next few years, genomic and post-genomic experiments that discover genes,
match them to their protein products, and match these products to the mechanics of
living organisms will dramatically shift the “starting line” for understanding what goes
wrong when we get sick and for unraveling the mysteries of how infectious agents
exploit our bodies for their own ends.
As these new approaches develop, they will affect the spectrum of human health,
but understanding the entities that cause infection must remain a top priority. Infectious
diseases kill more than 13 million people worldwide each year, half of them children
younger than five years old. Curing, controlling, or eliminating deadly acute infections
will dramatically improve the lives of countless people. In recent years, research has
shown new links between infectious agents and maladies such as cancer, peptic ulcer,
and neuromuscular and heart diseases, which in earlier days were thought to arise from
lifestyle factors and metabolic aberrations. In addition, a better understanding of infec-
tious diseases is now seen as central to approaching other chronic health problems
that have not yet been linked to infectious agents. 
New challenges beckon, but some older ones remain. Antibiotic resistance is on
the rise among infectious organisms of all kinds, threatening to wipe out the previous
generation’s advances against disease. Developing new antibiotics, new vaccine strategies,
new drug targets, and new insights into how to keep people from getting sick in the
first place has become more important than ever.
The Fund’s philosophy has always been that the most effective use of our limited
grant dollars is to use them as a catalyst that will open up new routes to innovation. 
In 2001, we have reoriented our spending in infectious diseases to better meet this goal.
BWF’s approach in infectious diseases has been oriented toward helping strengthen
the careers of scientists within specific, limited fields (first in parasitology, and then later
in mycology) and toward recruiting strong researchers from other areas to bring new
insights and new approaches to studying these pathogens. Going forward, we will use
the career development approach to encourage the development of researchers at the
interface between human and pathogen biology. 
Investigators in Pathogenesis of Infectious Disease, a new program launched in 2001,
is a career development program that will encourage investigators early in their careers
to pursue emerging avenues of research. To take advantage of recent developments in
genomics, immunology, and other areas, the program will provide researchers at the
assistant professor level an opportunity to bring aggressive, multidisciplinary approaches
to investigating infectious disease.
The program will sponsor work focused on the host, as well as the host-pathogen
interaction in viral, bacterial, fungal, or parasite systems, in an effort to understand how
these organisms interact with the host. Awards in this program will give recipients the
freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects
that hold potential for bringing about significant advances in the biochemical, pharma-
cological, immunological, and molecular biological understanding of how infectious
agents and the human body interact.
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Giving hookworms the hook
Hookworm infection is a major
cause of anemia and malnutrition
in many developing nations,
with global estimates of infection
at 1 billion people. Dr. Michael
Cappello of Yale University
School of Medicine, a 1999
New Investigator in Molecular
Parasitology, is working to uncover
the chemical and biological 
factors that enable the hookworm
to cause anemia. Using models
of animal and human hookworms
of the genus Ancylostoma, shown
here, he is working to develop a
vaccine that will prevent anemia
and growth delay in children and
adults with chronic infection. 
Work in this area can take many forms, but some potential frameworks for proposals
include:
• Studies of cell-pathogen interactions. This may include studies of host cell responses
at the cell surface, cell signaling in response to infection, microbial persistence
in host cells, and other processes occurring at the level of the host cell. 
• Studies of host-pathogen interactions. This may include studies of how the host’s
genes influence resistance to and susceptibility to infectious disease, as well as
studies of innate and adaptive immune responses to infectious agents and pathogen
modulation of the immune system. 
• Studies of novel routes to disease causation in humans. These may include studies
of the role of infectious agents in causing chronic diseases (e.g., heart disease)
and as triggers of immunologic and autoimmune disease.
Studies of what makes humans susceptible to particular diseases will fit into this
program, as will studies of human resistance to diseases. In keeping with the Fund’s
interest in concentrating our support on research in underserved fields, the program
will have a particular interest in work on under-studied infectious diseases, including
those caused by pathogenic fungi, metazoan parasites, and emerging virus pathogens.
The Investigators in Pathogenesis of Infectious Disease program is now the only BWF
competitive award program specifically focused on funding investigator-initiated research
in infectious disease. It supersedes several programs, including the New Investigator
and Scholar Awards in Molecular Pathogenic Mycology, New Investigator and Scholar
Awards in Molecular Parasitology, and New Initiatives in Malaria Research awards. It
does not replace these programs so much as it helps to move them forward, closer to the
ultimate goal of understanding how humans and their pathogens coexist, in hope of
some day eliminating the effects of infectious diseases. 
The program is intended to help shed light on the overarching issues of how the
human host handles infectious challenges. And, of course, the program has an important
second goal: to foster and build the careers of researchers who will move infectious
disease research toward Henry Wellcome’s goal of alleviating human suffering.
Taking a Longer View
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Basic Biomedical Sciences
Encouraging academic research careers
Creating confidence. Encouraging freedom of exploration. Boosting career prospects.
These are the goals of the Career Awards in the Biomedical Sciences program. 
Launched in 1995, the career awards program seeks to identify highly talented 
biomedical scientists during their formative periods and provide them the support they
need to become independent investigators. To date, we have awarded more than 
$70 million to support 148 U.S. and Canadian scientists.
BWF’s career awards are made in honor of Dr. Gertrude B. Elion (1918-99) and
Dr. George H. Hitchings (1905-98), two pioneering scientists who played major roles
in the Fund’s history. Dr. Elion served on our Board of Directors from 1991 to 1999,
and Dr. Hitchings served as our president from 1974 to 1990. Among their numerous
professional honors, Dr. Elion and Dr. Hitchings shared the 1988 Nobel Prize in
Physiology or Medicine for a series of scientific breakthroughs that revolutionized the
world of drug design.
The grants offers five years of salary and research support for biomedical scientists
during their advanced postdoctoral training and initial faculty years. Each year, we
award 20 or more grants of $500,000 each to degree-granting institutions in the United
States and Canada on behalf of individual scientists. Complete program information
can be found on our Web site at www.bwfund.org.
The 23 grantees who received career awards in 2001 are working across a broad range
of disciplines. For example, Stanford University’s Karen Guillemin, Ph.D., is conducting
experiments on the bacterium Helicobacter pylori, which has been linked to stomach
ulcers and stomach cancer, the second leading cause of cancer deaths worldwide, while
Kathleen Caron, Ph.D., of the University of North Carolina-Chapel Hill, will examine
the role of a protein, adrenomedullin, that has been found in high levels in patients with
cardiovascular disease resulting in high blood pressure.
After six years of funding the research of scientists as they make the transition from
postdoctoral fellow to assistant professor, the Fund has gathered enough data to begin
to evaluate the impact of this popular competitive award program. We are proud of the
fact that virtually all awardees who have become eligible for faculty appointments have
received tenure-track or equivalent positions, with start-up packages averaging just over
$450,000 for those obtaining faculty positions in 2000.
Surveys of awardees show that most say their career award helped “a great deal” in
obtaining and shortening the time to a faculty position, increasing subsequent success
in obtaining grant support, and increasing their independence and ability to do “higher-
risk” research. 
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OVERVIEW OF BWF PROGRAMS
In fiscal 2001, the Burroughs Wellcome Fund approved $39.8 million in new grants and paid out $34 million in new and continuing grants. We
supported a total of more than 600 grants at 170 academic and other nonprofit institutions across the United States and Canada. More than 
90 percent of these grants are intended to support the research of scientists who were nominated by their institutions, which receive and administer
the grants.
“It’s very competitive out there;
good faculty positions are few
and far between. This award
gives me a lot of negotiating
possibilities.”
— Bryan Sutton, Ph.D., 
2000 Career Award in the Biomedical
Sciences recipient 
In a fly’s eye
Using time-lapse microscopy,
Dr. Carrie Baker Brachmann 
of University of Washington
School of Medicine, a 2001
Career Awardee in the
Biomedical Sciences, studies
the mechanism by which a fly’s
cells form and then selectively
die off, creating the precise 
patterning of the adult fly’s 
eye. The fly is a good model 
for understanding how many 
tissues in developing organisms
are shaped by the programmed
death of unnecessary cells. 
As shown on this page, career awardees have been successful in obtaining follow-on
support for their work. However, the evaluation data, which will be published in their
entirety in 2002, do not indicate how awardees fare in relation to those applicants who
did not get an award. To address this issue, in 2002 the Fund will undertake a controlled
study of selected outcomes that compares those who received an award to those who
applied, but did not receive an award. These data, which BWF intends to publish, will
be used to help determine if we are doing a good job in selecting grant recipients. It
will be one of the first such comparative studies carried out by a private funding agency,
and its results will guide BWF’s future selection processes.
Our evaluation program is simply an extension of the Fund’s philosophy that fostering
the careers of our awardees extends well beyond the grant support provided. In addition
to providing funds, we seek to provide opportunities, such as awardee meetings, to help
build a network of professional connections that can provide support, advice, and oppor-
tunities for scientific collaboration. All but three of the 48 award recipients in 2000
and 2001 attended the 2001 career awardee meeting, held at BWF headquarters in
Research Triangle Park, North Carolina, along with several BWF board members, staff,
and former career awardees. The awardees gathered to present their BWF-sponsored
work and to network with each other, the board, and staff. The two-day meeting provided
a chance to explore critical career development topics, such as how to negotiate a faculty
position, lab management, dual-career couples, and seeking federal grant support. 
The Fund also awarded BWF Research Travel Grants to 39 U.S. and Canadian
researchers to enable them to visit colleagues in the United Kingdom or Ireland for
shorter periods (two weeks to six months). The grants support collaboration on research
projects or the learning of new research techniques. This round of grants, awarded in
February 2001, was the last BWF will make in this program.
Infectious Diseases
Building a stronger scientific base
Five BWF programs in infectious diseases—Scholar and New Investigator Awards in
Molecular Parasitology, Scholar and New Investigator Awards in Molecular Pathogenic
Mycology, and New Initiatives in Malaria Research—ran their final award cycles in
2001. These programs have focused on establishing a foundation of knowledge that will
shift the balance toward more effective treatments for endemic and epidemic infectious
diseases.
In 2001, BWF made two scholar awards and three new investigator awards to 
scientists working in molecular parasitology, and one scholar award and three new
investigator awards to scientists working in molecular pathogenic mycology. The awards
are intended to encourage scientists to use modern techniques from molecular biology,
biochemistry, immunology, pharmacology, and genetics to advance fundamental knowledge
of virulent disease-causing parasites and fungi.
The New Initiatives in Malaria Research awards are intended to attract investigators,
often from other fields, to work on malaria, encouraging them to bring novel approaches
to the study of the disease and the vectors that spread it. This year, seven researchers
shared six awards.
Overview of BWF Programs 
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NIH Grants of Career 
Awardees in Faculty Positions*
(Awardees with one or more 
R01 or R29 grants)
Total
N % N
PH.D. only 12 33 36
M.D. & M.D.-Ph.D. 14 56 25
Total 26 43 61
*Includes awardees who were 
in faculty positions for seven or
more months.
Additional Research Funding 
Obtained by Career Awardees in
Faculty Positions* (Total annual
direct costs in FY 2000)
Median $183,995
Mean $212,725
Range $13,200-$635,000
Respondents 46
*Includes awardees who were 
in faculty positions for seven or
more months.
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BWF continues to support two training courses, conducted at the Marine Biological
Laboratory in Woods Hole, Massachusetts, that are focused on training researchers 
to work in parasitology and mycology. The courses are tailored to provide advanced
independent investigators, graduate students, and postdoctoral fellows with practical
laboratory skills, pedagogical lectures, research seminars, and informal interactions
with top researchers in these fields.
The international effort to sequence the genome of Plasmodium falciparum, the
most dangerous form of the parasite that causes malaria, has made large strides, with
completion of the genome expected by 2002, one year earlier than predicted in last year’s
annual report. The project is supported by BWF, the Wellcome Trust, the National
Institute of Allergy and Infectious Diseases, the Department of Defense, and the World
Health Organization. Another BWF investment supports the development of the project’s
database, PlasmoDB, which brings together all of the information generated by the
project and provides the research community with on-line tools for analyzing the data. 
Interfaces in Science
Erasing boundary lines among disciplines
Young, talented, and ambitious scientists from many physical science disciplines and
mathematics are being drawn into biology by the prospect of unraveling, understanding,
and predicting the design and behavior of living systems. Scientists from these theory-rich
areas are beginning to realize that the opportunity to make a significant contribution to
a new frontier of science is well within their reach.
BWF recognizes that in order for these scientists to make the transition to studying
biological systems, a new type of training must be available to them. Since 1996, BWF
has committed $24 million to our Institutional Awards at the Scientific Interface program.
The only organizational requirement imposed by BWF is that programs are to be directed
by pairs of scientists, one with a background in biology and one with a background in
a physical, theoretical, or computational discipline. None of the 10 currently funded
programs is organized in precisely the same way, but rather each capitalizes on its own
unique scientific strengths, institutional capabilities, and inter-institutional connections.
In 2001, four awards were made: Boston University, which received $1.75 million;
and Princeton University, the University of Chicago, and the University of California-
San Francisco, which each received $2.5 million. 
The training program at Princeton University is directed by John Hopfield, Ph.D.,
professor of molecular biology, and Simon Levin, Ph.D., George M. Moffett Professor 
of Biology. This program, which exemplifies the type of research funded by the interfaces
institutional awards, will challenge physical scientists to apply their training in complex
system modeling to understand the behavior of biological systems. The program will offer
graduate students the opportunity to receive training in the emerging field of biological
dynamics.
In 2001, BWF launched a new individual award program to complement our 
institutional award program: Career Awards at the Scientific Interface. This program
will provide each award recipient with up to $538,000 over five years to support up 
to two years of advanced postdoctoral training and the first three years of a faculty
appointment. Modeled after our Career Awards in the Biomedical Sciences, these awards
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“No amount of reading or course
work can replace working side-
by-side with biologists.” 
— Stephen Kron, M.D., Ph.D., 
program director, 
Cross-Disciplinary Training Program 
in Biophysical Dynamics, 
University of Chicago
PH.D. BACKGROUND 
OF POSTDOCTORAL TRAINEES 
(from six BWF Interfaces training
programs awarded in 1996 
and 1998)
Computer Science 
(9 percent)
Chemistry (9 percent)
Other (7 percent)
Bioengineering (5 percent)
Biology (Structural) (2 percent)
Biophysics (7 percent)
Mathematics 
(14 percent)
Biology/Biochemistry (12 percent)
Physics (35 percent)
Overview of BWF Programs 
13
are open to scientists who have earned a doctoral degree in one of the physical sciences
and are working on biological research problems. We believe that by offering these
uniquely trained individuals independent funding during their postdoctoral training,
their value will be affirmed and they will be more attractive to future employers. Indeed,
many top-tier research universities are actively recruiting faculty with interdisciplinary
credentials.
As part of BWF’s increased emphasis on evaluation of our programs, we have
implemented a yearly on-line progress-reporting system and anonymous on-line survey
of trainees in the interfaces programs. We designed the trainee survey to be anonymous
so that people would feel free to be completely open and honest about the quality of
their training experience. We liken the survey to an “electronic interview,” in which we
can gather information and feedback for course and program directors that will help
ensure continual improvement of this entirely new type of interdisciplinary training. In
July 2001, we surveyed 100 pre- and postdoctoral trainees now enrolled in the interfaces
programs. The figures on pages 12 and 13 are based on these surveys and show the distri-
bution of academic backgrounds of the trainees who received support in 2001.
We found that many of the trainees, who as mathematicians or computer scientists
had never done an experiment, valued the opportunity to work in a laboratory alongside
biologists. In the words of one trainee from the Computational Molecular Biology program
at the California Institute of Technology, “The program gave me the chance to walk into
a biology lab, with almost no background, and start doing experiments immediately.”
Trainees said they feel that they are not only learning to understand biology, but also
learning how to identify important questions in biology. BWF fellows in these programs
are given many opportunities to present their work, both orally and in writing, and thus
are developing the communication skills needed to succeed as interdisciplinary researchers.
Fully 75 percent of these fellows report that they intend to pursue careers in academia,
and the early indications are that they have no problem landing faculty positions in
top research universities. Of the program “alumni” who were supported as postdoctoral
fellows during the past four years, 37 percent are already in tenure-track positions. In
some cases, fellows move directly from graduate school into faculty positions because
their talent is so rare.
One trainee from the La Jolla Interfaces in Science Training Program summed up
his experience this way: “My willingness to pursue interactions with and training in a
biological field was one of the aspects of my work that seemed to most impress interviewers
during my job interviews. This focus on ‘interdisciplinary’ may have been the deciding
factor for the institutions for which I received job offers.”
Chemistry (22 percent)
Physics (20 percent)
Other (5 percent)
Engineering (14 percent)
Biology (12 percent)
Computer Science 
(2 percent)
UNDERGRADUATE DEGREES
OF PREDOCTORAL TRAINEES
(from six BWF Interfaces training
programs awarded in 1996 
and 1998)
Math/Statistics (25 percent)
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Translational Research
Advancing medicine in the lab and at the bedside
From our genesis as a corporate philanthropy, BWF has made support of physician-
scientists a cornerstone of our grant-making strategy. Our long-standing commitment to
experimental therapeutics and to clinical pharmacology has matured into our current
emphasis on bolstering the careers of clinical investigators in a variety of fields. The Fund
has been at the forefront both in drawing attention to the specific needs of the patient-
oriented researcher and in providing direct financial support for established clinical
investigators through our Clinical Scientist Awards in Translational Research program.
Over its four-year history, this program has undergone a steady evolution as the
scientific advisory committee has honed its vision of what can be considered “translational
research.” The program now targets investigators who are on the brink of translating basic
science findings into a potential clinical application, as well as those whose clinical insight
invites laboratory investigation of potential therapeutic avenues. Despite the critical
contribution to medicine of these types of investigations, there are few nonprofit sources
of support for translational research. Many physician-scientists recognize that a more
straightforward path to a successful career can be had if their research is confined to the
laboratory, where significant research results are not as hard-won as they are in the clinic.
Those who wish to pursue patient-oriented research face many disincentives in academic
health centers, and as a result fewer new graduating medical students are interested in
these careers.
This is one of the reasons that BWF’s awards are targeted at the mid-career, rather
than new investigator level. In addition to promoting scientific excellence, BWF seeks
to identify the “mentor phenotype,” or those investigators who have a track record of
attracting young talent into their laboratories. These awards are designed to increase the
capacity of these proven, enthusiastic mentors, so that the careers of more physician-
scientists may be directed into patient-oriented research. With the addition of the latest
cohort of awardees in 2001, BWF currently supports 39 investigators who are collectively
mentoring more than 125 physician-scientists at various training levels.
BWF has become more active during the past year in initiating discussions among 
a group of 11 private organizations whose interests in the career development of
patient-oriented researchers overlap with our own, as highlighted in this year’s president’s
message (see p. 5). The sharing of program data and strategies among the group has
enabled the organizations to better target their initiatives to the needs of young clinical
investigators, and has engendered a fuller commitment to collaboration without sacrificing
each organization’s distinctive mission.
Five of the organizations in the group collaborated to fund Clinical Research 2001,
a joint meeting organized by the American Federation for Medical Research, the Association
for Patient-Oriented Research, and the General Clinical Research Center Program Directors’
Association. Held in Washington, D.C., in March 2001, the meeting attracted more than
300 participants, including 53 trainees from institutions across the United States and
Canada. This foundation-catalyzed association of five professional societies is now well
positioned to make a greater collective impact on the issues that prevent potential clinical
researchers from entering these careers. In the coming year, BWF looks forward to working
to strengthen this alliance of associations and foundations.
“I think is very important that
we as researchers realize that
the work that we are doing goes
beyond our own ego and has
potential application to real
human problems.”
— Joyce Slingerland, M.D., Ph.D., 
assistant professor of medicine,
University of Toronto Faculty 
of Medicine, and 1998 
Clinical Scientist Award in
Translational Research recipient
Overview of BWF Programs 
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BWF’s current focus on translational research builds on our strong tradition of
supporting the fields of toxicology and pharmacology, dating back to our origins as a
corporate foundation. In recent years, more and more of the Fund’s support of these
areas has gone to researchers working in areas that integrate biology with the physical
sciences. Recognizing the shift in scientific focus taking place, the Fund decided to shift
resources from the New Investigator Awards in the Pharmacological and Toxicological
Sciences into the Fund’s Interfaces programs, which directly target physical scientists
and encourage them to work on biological problems. This year, 10 basic scientists at
the beginning stages of their faculty careers received the final BWF New Investigator
Awards in the Pharmacological or Toxicological Sciences. 
Science Education
Reaching out to students, teachers, and policymakers
Scientific discovery and technology innovations are needed to solve many of the world’s
problems, such as feeding and providing energy to a growing population, improving
human health, and protecting the environment. Technological innovation as the engine
of economic growth creates jobs, builds new industries, and improves people’s standard
of living. These innovations affect everyone’s daily lives in ways that we now take for
granted, such as banking or grocery shopping. 
BWF believes that in order for students to realize their full potential within a 
technological society, they must possess the knowledge and skills needed to prepare for
the high-technology jobs of the future, to become leaders in scientific research, and 
to participate in the global economy. 
Although the issues are global, the Fund has chosen to focus our efforts in science
education in our home state of North Carolina. We first established the Student Science
Enrichment Program (SSEP) in 1994 to provide middle school and high school students
with science-rich activities outside the traditional classroom environment. BWF has
invested more than $7 million through the SSEP, reaching more than 23,000 students
through programs offered by 36 different organizations. SSEP’s goals are to nurture
students’ enthusiasm for science, improve their competence in science, and encourage
them to pursue careers in research or other science-related disciplines. In 2001, BWF
awarded $1.1 million to nine organizations across the state that will offer activities
centered around solving problems, thinking critically, learning the scientific method
through hands-on science inquiry, and using technology.
Recognizing the need to do more to improve the way science, mathematics, and
technology are taught and learned in North Carolina, BWF partnered with the North
Carolina Public School Forum to establish an Institute for Educational Policymakers 
in 1996. The goal of the institute is to build the capacity of and relationships among
legislators, State Board of Education members, K-12 education leaders, business leaders,
and members of the media who cover education. The institute has exposed education
policymakers to a wide array of educational “best practices,” and this exposure has
translated in several instances into new initiatives. In addition, there has been a dramatic
improvement in working relationships among education policymakers from differing
political parties and those individuals serving in various legislative branches or appointed
governing boards. Local capacity-building programs for school board members have
been modeled after the institute and are now running in the state’s largest school 
systems. A reference manual developed by the institute, Primer on Educational Policy
(collaboration among the Forum, East Carolina University, and McGraw Hill Publishers),
will soon be published as a textbook for use in Schools of Education at North Carolina
universities. Other states, most notably Georgia and Kentucky, have examined the
institute’s work and are beginning similar programs.
Seeing the light
Retinitis pigmentosa (RP) is an
inherited disease in which the
light-sensitive portion of the eye,
the retina, slowly degenerates,
leading to blindness. One in 
80 Americans is a carrier for
RP. Dr. Stephen Tsang, of the
Jules Stein Eye Institute at 
the University of California-Los
Angeles School of Medicine,
studies defects within a mouse’s
eye (shown here). Dr. Tsang,
a 2001 Career Award in the
Biomedical Sciences recipient,
hopes that his studies, conducted
in Dr. Debora Farber’s laboratory,
will provide clues to new therapies
for RP, macular degeneration,
and other degenerative diseases
of the retina.
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In 2001, an international exchange program developed by the institute enabled
education leaders to travel to the Netherlands to visit schools, meet students, and converse
with teachers and administrators. The primary purpose of the trip was to review methods
and practices used in science and mathematics education in order to better understand
the reasons students in other countries, including the Netherlands, consistently score
better on performance tests than do U.S. students.
When scientists are asked where they first became interested in science, many say
it happened while visiting museums as children. Thus, reaching the museum community
is an important goal for BWF. In 2000, the Fund provided a grant to the science museum
community in North Carolina to establish the Grassroots Science Museum Collaborative,
which is the first such collaborative in the United States. The collaborative coordinates
the activities of 19 science museums across the state and integrates these efforts with
school activities to better reach not only children, but also teachers, parents, and grandparents.
In 1995, the North Carolina Public School Forum published a report titled “The
State of Disconnectedness: An Examination of Mathematics and Science Instruction 
in the North Carolina Public Schools,” which showed that poor communication and
disconnected, isolated science education initiatives hamper efforts to improve science,
mathematics, and technology education in the state. In 2001, BWF responded by
establishing a neutral, nonprofit entity to function as a science, mathematics, and 
technology education champion for North Carolina. By developing collaborative partner-
ships among those responsible for and interested in promoting science education, BWF
hopes to move the state from isolated model programs to an integrated strategy that
will provide high-quality science education for all of the state’s students.
In a world filled with products of scientific inquiry, scientific literacy has become 
a necessity for everyone. We all need to be able to use scientific information to make
choices that arise on a daily basis. At the Fund, we believe everyone deserves to share
in the excitement and personal fulfillment that can come from understanding and
learning about the natural world, and we hope that through our efforts, we will help
make science literacy a reality for all students. Math test
Cells are highly regulated 
subunits of every tissue in the
human body. One of the ways
that cells communicate is by
direct contact, in a so-called
synaptic junction. Dr. Jay Groves
of the University of California-
Berkeley, a 2000 BWF Career
Award in the Biomedical
Sciences recipient, is studying
the physical patterns of proteins
at the synaptic junction between
two immune system cells as
they communicate, shown here
as a visual representation of a
mathematical model.  
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The Burroughs Wellcome Fund’s investments totaled $639.6
million at August 31, 2001, the end of our fiscal year. BWF’s
primary financial goal is to pursue an investment strategy
that will support annual spending needs and maintain a
constant real level of assets over the long term. To achieve
this goal, a very high percentage of our investments is placed
in strategies that derive the bulk of their returns from exposure
to U.S. and international capital markets. Hence, fluctuations
in BWF’s investment results will be due largely to variability in
capital market returns.
BWF’s investment policies are developed with the recom-
mendations and review of the Investment Committee, which
is appointed by and reports to BWF’s Board of Directors. The
committee, which meets three times a year, has seven voting
members, including four representatives from outside BWF
and three representatives of our board. The board’s chair,
BWF’s president, and BWF’s vice president for finance also
serve on the committee as nonvoting members.
As part of BWF’s investment strategy, we have established
“allocation targets”—that is, percentages of our total assets
to be invested in particular asset classes. Investment managers
hired by BWF pursue more focused mandates within each
sector. As of the end of the fiscal year, BWF’s asset mix and
market values were:
• U.S. large capitalization equity assets had a market
value of $179.9 million. The sector’s target allocation
was 31 percent, and actual holdings stood at 28.1
percent.
• U.S. small capitalization equity assets had a market
value of $91.5 million. The sector’s target allocation
was 14 percent, and actual holdings stood at 14.3
percent.
• International equity assets had a market value of
$160.9 million. The sector’s target allocation was 
30 percent, and actual holdings stood at 25.2 percent.
• Fixed income assets had a market value of $158.3
million. The sector’s target allocation was 22 percent,
and actual holdings stood at 24.7 percent.
• Cash equivalent assets had a market value of $10.9
million. The sector’s target allocation was 3 percent,
and actual holdings stood at 1.7 percent.
• Alternative assets had a market value of $38.1 million.
The sector did not have a target allocation, and actual
holdings stood at 6 percent. The maximum permitted
allocation to alternative assets stood at 8 percent.
The total market value of BWF’s investments decreased by
$124.1 million, or 16.2 percent, from the end of the previous
fiscal year. This large decrease in assets was due primarily to
poor returns in world equity markets over the course of the
fiscal year. BWF’s total investment return for the fiscal year
was -11 percent. The two sectors that drove this result were
the international equity sector, which posted a return of -25.4
percent for the fiscal year, and the U.S. large capitalization
equity sector, which had a -17.1 percent return. U.S. small
capitalization equities had an -8.2 percent return, while fixed
income produced a 13.7 percent result.
As of August 31, 2001, BWF employed 11 investment
managers. In the U.S. large capitalization equity sector, 
the managers were Independence Investment Associates;
Westpeak Investment Advisors; and Cohen, Klingenstein and
Marks. Credit Suisse Asset Management; Kennedy Capital
Management; and Scudder Kemper Investments managed U.S.
small capitalization equities. Pacific Investment Management
Company and Smith Breeden Associates were the fixed income
managers. Capital Guardian Trust Company and Hansberger
Global Investors managed international equities. State Street
Global Advisors managed a hedge fund. BWF also held
investments in six venture capital funds: Intersouth Partners
IV and V, the Spray Venture Fund, Mission Ventures II, the
North Carolina Bioscience Investment Fund, and Tech Amp II.
Finally, the increase in the allocation to alternative
investments from that of August 2000 was mainly the result
of a December 2000 investment in a fund of approximately
20 alternative investment strategies overseen by Quellos Capital
Management. This fund expects to generate equity-like returns
over time without systematic exposure to returns in world
capital markets. To the extent this strategy helps reduce the
variability of BWF’s investment returns through time, year-
to-year grant and operating expense payout will be easier for
BWF to manage.
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FINANCIAL STATEMENTS AND ADDITIONAL INFORMATION
Report of Independent Accountants
To the Board of Directors of 
The Burroughs Wellcome Fund
In our opinion, the accompanying statements of financial position and the related statements of activities and of cash flows
present fairly, in all material respects, the financial position of The Burroughs Wellcome Fund (the “Fund”) at August 31, 2001
and 2000, and the changes in its net assets and its cash flows for the years then ended in conformity with accounting 
principles generally accepted in the United States of America. These financial statements are the responsibility of the Fund’s
management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted
our audits of these statements in accordance with auditing standards generally accepted in the United States of America,
which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements, assessing the accounting principles used and significant estimates made by management, and
evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for the opinion
expressed.
Our 2001 audit was conducted for the purpose of forming an opinion on the basic financial statements taken as a whole.
The information presented in Schedule I is presented for purposes of additional analysis and is not a required part of the
basic financial statements. Such information has been subjected to the auditing procedures applied in the audit of the basic
financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements
taken as a whole.
Raleigh, North Carolina
October 5, 2001
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2001 2000
ASSETS
Cash and cash equivalents $ 44,825 $ 33,473
Marketable securities 635,880 781,162
Accrued interest and dividends receivable 2,156 2,480
Federal excise tax receivable 1,403 -
Other assets 22 31
Total current assets 684,286 817,146
Property and equipment, net 14,590 14,999
Total assets $ 698,876 $ 832,145
LIABILITIES AND NET ASSETS
Transactions payable, net $ 42,544 $ 52,425 
Accounts payable and other liabilities 960 1,064 
Unpaid awards 78,888 70,028 
Deferred federal excise tax liability - 1,985 
Total liabilities 122,392 125,502 
Commitments and contingencies (Note 6)
Unrestricted net assets 576,484 706,643 
Total liabilities and net assets $ 698,876 $ 832,145
The accompanying notes are an integral part of these financial statements.
Statements of Financial Position
August 31, 2001 and 2000
(All dollar amounts presented in thousands)
Financial Statements 
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Financial Statements 
Years Ended August 31, 2001 and 2000
(All dollar amounts presented in thousands)
2001 2000
Revenues:
Interest and dividends, less investment expenses of $4,254 
and $3,627 in 2001 and 2000, respectively $ 14,848 $ 16,423
Net realized gain on sales of marketable securities 3,654 99,422
Total revenues 18,502 115,845
Expenses:
Program services 42,655 39,223
Management and general 4,960 4,799 
Total expenses before federal excise tax 47,615 44,022 
Net unrealized (depreciation) appreciation of marketable securities,
net of (benefit from) provision for deferred federal excise taxes
of $(1,985) and $406 in 2001 and 2000, respectively (102,449) 19,805
Federal excise tax benefit (expense) 1,403 (2,155) 
Total net (depreciation) appreciation and federal excise tax benefit (expense) (101,046) 17,650 
Change in net assets (130,159) 89,473
Net assets at beginning of year 706,643 617,170 
Net assets at end of year $ 576,484 $ 706,643 
The accompanying notes are an integral part of these financial statements.
Statements of Activities
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Years Ended August 31, 2001 and 2000
(All dollar amounts presented in thousands)
2001 2000
Cash flows from operating activities:
Change in net assets $ (130,159) $ 89,473
Adjustments to reconcile change in net assets
to net cash (used in) provided by operating activities:
Depreciation 730 517
Net realized gain on sales of marketable securities (3,654) (99,422)
Net unrealized depreciation (appreciation) of marketable securities 104,434 (20,211)
(Benefit from) provision for deferred federal excise taxes (1,985) 406
Awards granted, net of cancellations and change in unamortized discount 42,943 39,453
Award payments made (34,083) (32,820)
Changes in operating assets and liabilities:
Decrease (increase) in transactions payable, net (9,881) 40,704
Decrease in accrued interest and dividends receivable 324 318
Increase in federal excise tax receivable (1,403) -
Decrease in other assets 9 21
Decrease in accounts payable and other liabilities (104) (91)
Net cash (used in) provided by operating activities (32,829) 18,348
Cash flows from investing activities:
Purchases of marketable securities (1,434,649) (1,547,198)
Proceeds from sales of marketable securities 1,479,151 1,529,008
Purchase of property and equipment (321) (3,518)
Net cash provided by (used in) investing activities 44,181 (21,708)
Net increase (decrease) in cash and cash equivalents 11,352 (3,360)
Cash and cash equivalents at beginning of year 33,473 36,833
Cash and cash equivalents at end of year $ 44,825 $ 33,473
Supplemental disclosure of cash flow information:
Cash paid during the year for federal excise taxes $ - $ 2,155 
The accompanying notes are an integral part of these financial statements.
Statements of Cash Flows
Financial Statements 
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Years Ended August 31, 2001 and 2000
(All dollar amounts presented in thousands)
1. Organization and Summary of Significant Accounting Policies
The Burroughs Wellcome Fund (the “Fund”) is a private foundation established to advance the medical sciences by supporting research and
other scientific and educational activities.
Cash equivalents
Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and have a maturity of three
months or less at the time of purchase. 
Forward currency contracts
The Fund enters into financial instruments with off-balance sheet risk in the normal course of its investment activity, primarily forward contracts,
to reduce the Fund’s exposure to fluctuations in foreign currency exchange rates. These contracts are for delivery or sale of a specified amount
of foreign currency at a fixed future date and a fixed exchange rate. Gains or losses on these contracts occur due to fluctuations in exchange rates
between the commencement date and the settlement date. Gains and losses on settled contracts are included within “net realized gains or losses on
sales of marketable securities,” and the changes in market value of open contracts is included within “net unrealized appreciation (depreciation)
of marketable securities” in the accompanying statements of activities. It is the Fund’s policy to utilize forward contracts to reduce foreign exchange
rate risk when foreign-based investment purchases or sales are anticipated.
The contract amount of these forward currency contracts totaled $5,152 and $2,676 at August 31, 2001 and 2000, respectively. Realized gain
(loss) on forward currency contracts totaled $669 and ($608) in 2001 and 2000, respectively. The market value of open forward currency contracts
at August 31, 2001 and 2000 was $298 and $317, respectively. The market value is recorded as an asset in the Fund’s financial statements. The
average market value of open foreign currency contracts totaled $233 and ($238) for the years ending August 31, 2001 and 2000, respectively.
Futures contracts
The Fund enters into futures contracts in the normal course of its investment activity to manage the exposure to interest rate risk associated with
bonds and mortgage backed securities. The Fund is required to pledge collateral to enter into these contracts. The amounts pledged for futures
contracts at August 31, 2001 and 2000 were $1,777 and $235, respectively. It is the Fund’s intention to terminate these contracts prior to final
settlement. Gains and losses on the contracts are settled on a daily basis. Included in transactions payable at August 31, 2001 and 2000 is the
net settlement relating to these contracts of $11 and $0, respectively.
Options
The Fund utilizes options to manage the exposure to interest rate risk associated with mortgage backed securities. The market value of these
options totaled $1,504 and $23 at August 31, 2001 and 2000, respectively, which is recorded as an asset in the Fund’s financial statements.
The average fair value of open contracts totaled $610 and ($816) for the years ending August 31, 2001 and 2000. Realized losses on options
totaled $214 and $2,450 for the years ending August 31, 2001 and 2000, respectively.
Marketable securities
Marketable securities are carried at estimated market values based on quoted prices. Gains and losses from sales of securities are determined on
an average cost basis and are recognized when realized. Changes in the estimated market value of securities are reflected as unrealized appreciation
or depreciation in the accompanying statements of activities. The Fund has investment advisors which manage its portfolio of marketable securities.
The Fund’s management critically evaluates investment advisor performance and compliance with established diversification and investment policies.
Notes to Financial Statements
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Property and Equipment
Property and equipment is primarily comprised of a building, furniture, and computer equipment which are stated at cost less accumulated
depreciation and are being depreciated over their estimated useful lives using the straight-line method. Ordinary maintenance and repair costs
are expensed as incurred.
Building 40 years
Furniture and Fixtures 7 years
Computer Equipment 3 years
Transactions receivable and transactions payable, net
These amounts represent the net receivable or payable resulting from investment transactions with trade dates prior to August 31 and settlement
dates subsequent to August 31.
Awards granted and unpaid awards
Grants are expensed at their fair value in the year in which the award is granted. Grants payable over several years are expensed, and carried 
on the statements of financial position, at the present value of their estimated future cash flows, using a risk free discount rate determined 
at the time the award is granted.
Functional allocation of expenses
Costs of the Fund’s operations and activities have been summarized on a functional basis in the statement of activities.
Estimated fair value of financial instruments
Financial instruments include cash and cash equivalents, marketable securities, accrued interest and dividends receivable, accounts payable,
and unpaid awards. All financial instruments are reported at their estimated fair value. The carrying values of accrued interest and dividends
receivable, accounts payable, and unpaid awards approximate fair values based upon the timing of future expected cash flows. The estimated
fair value of marketable securities is determined based upon the latest quoted sales price for such securities as of the balance sheet date. The
Fund’s remaining assets and liabilities are not considered financial instruments.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those 
estimates.
Market Risk
Market risk represents the risk of changes in value of a financial instrument, derivative or non-derivative, caused by fluctuations in interest rates,
foreign exchange rates and equity prices. The Fund manages these risks by using derivative financial instruments in accordance with established
policies and procedures.
Reclassifications
Certain reclassifications were made to the August 31, 2000 financial statements to conform them to the August 31, 2001 presentation.
2. Property and Equipment
The Fund’s property and equipment consisted of the following:
2001 2000
Building $ 13,451 $ 13,361
Furniture and Fixtures 1,717 1,540
Computer Equipment 669 615
15,837 15,516
Less: accumulated depreciation (1,247) (517)
$ 14,590 $ 14,999
Financial Statements 
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3. Federal Excise Taxes
The Fund is exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code. However, since the Fund meets the definition
of a private foundation under the Internal Revenue code, it is subject to federal excise tax on its annual net investment income. The federal excise
tax receivable at August 31, 2001 represents an overpayment in fiscal 2000 due to the Fund qualifying at a 1% tax rate rather than the normal
2% tax rate.
Deferred federal excise taxes represent the tax liability on unrealized appreciation of marketable securities. At August 31, 2001, the Fund is in a
net unrealized depreciation position. Management has not recorded a deferred tax asset as there could be no reasonable assurance of its realization.
4. Unpaid Awards
Unpaid awards as of August 31 are scheduled for payment as follows:
2001 2000
Payable in less than one year $ 34,409 $ 28,710
Payable in one to five years 47,852 47,833
82,261 76,543
Unamortized discount (3,373) (6,515)
Total $ 78,888 $ 70,028
The expected future liability to the Fund has been calculated based on discount rates ranging from 2.56% to 6.70%.
5. Marketable Securities
The cost and estimated market values of marketable securities at August 31 are as follows:
2001 2000
Estimated Estimated
Market Market
Cost Value Cost Value
U.S. and foreign governmental obligations $ 110,968 $ 113,972 $ 136,483 $ 136,430
Corporate bonds 61,631 63,747 75,516 74,840
Common and preferred stocks 263,449 268,273 288,352 345,847
Foreign stocks and foreign equity fund 167,815 151,230 174,302 217,033
Option and forward foreign currency investments 6,148 6,077 68 136  
Venture capital investments 11,369 11,230 6,876 6,876
Mutual fund 20,000 21,351 - - 
$ 641,380 $ 635,880 $ 681,597 $ 781,162
6. Commitments
The Fund leased office space under an operating lease until December 1999. Rental expense for this lease was $0 and $41 in fiscal 2001 
and 2000, respectively.
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7. Employee Benefit and Retirement Plans
The Fund provides medical insurance to all employees working at least thirty hours per week. Coverage extends to each employee’s spouse and
dependent children, if applicable. The expense for this employee benefit was $88 and $99 during fiscal 2001 and 2000, respectively.
The Fund has a defined-contribution retirement plan covering all employees working at least twenty hours per week. Under the terms of the plan,
the Fund matches 50% of all employees’ contributions up to 6% of the employee’s annual compensation. Employees are 100% vested in employee
and employer contributions immediately. The Fund also has a defined-contribution retirement plan funded solely through employer contributions.
Under the terms of the plan, the Fund contributes 10% of the employee’s annual compensation. This plan covers all employees and vesting in
contributions is immediate. The expense for these retirement plans was $40 and $148 in fiscal 2001 and $37 and $136 in fiscal 2000.
8. Classification of Expenses
During the years ended August 31, expenses were classified as follows:
2001 2000
Management Management
Program and Program and
Services General Services General
Awards granted, net of cancellations 
and refunds of $6,221 and $6,770 
in 2001 and 2000, respectively $ 42,655 $ - $ 39,223 $ -
Salaries and other employee expenses - 2,171 - 1,960
Depreciation expense - 729 - 517 
Travel and entertainment - 749 - 595 
Maintenance and supplies - 616 - 764 
Honoraria - 323 - 351 
Professional fees - 178 - 313 
Printing and design costs - 89 - 144 
Rent - - - 41 
Miscellaneous - 105 - 114 
Total expenses $ 42,655 $ 4,960 $ 39,223 $ 4,799
Schedule I: Statement of Awards Granted
Year Ended August 31, 2001
Schedule I information is included in the “Grants Index” beginning on page 26. The dollar amounts listed in the schedule reflect the actual 
dollar amounts (not rounded to thousands) approved and paid to awardees.
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Program Summary
Approved Paid Transferred/
Cancelled*
BASIC BIOMEDICAL SCIENCES
Career Awards in the Biomedical Sciences $ 14,949,046 $ 9,641,446 $ 4,554,500
Career Awards Collaborative Grant 68,564 - -
Hitchings-Elion Fellowships 914,509 558,384 751,350
Life Sciences Research Fellowships 369,000 328,000 -
Obstetrics and Gynecology Research Fellowships 153,000 184,000 -
History of Medicine Travel Grants 5,524 5,524 -
BWF Research Travel Grants 274,837 299,013 7,024
Other Grants 727,000 615,500 -
TOTAL $ 17,461,480 $ 11,631,867 $ 5,312,874
INFECTIOUS DISEASES
Scholar Awards in Molecular Parasitology $ 1,275,000 $ 1,072,500 $ 382,500
New Investigator Awards in Molecular Parasitology 630,000 617,500 -
Scholar Awards in Molecular Pathogenic Mycology 425,000 1,082,500 -
New Investigator Awards in Molecular Pathogenic Mycology 630,000 795,000 -
New Initiatives in Malaria Research 1,300,000 1,430,000 -
Other Grants 563,072 1,102,731 213,372
TOTAL $ 4,823,072 $ 6,100,231 $ 595,872
INTERFACES IN SCIENCE
Institutional Awards at the Scientific Interface $ 11,250,000 $ 4,446,406 $ -
Innovation Awards in Functional Genomics - 889,583 -
Other Grants 490,384 190,384 -
TOTAL $ 11,740,384 $ 5,526,373 $ -
TRANSLATIONAL RESEARCH
Clinical Scientist Awards in Translational Research $ 7,500,000 $ 5,100,000 $ -
New Investigator Awards in the Pharmacological
or Toxicological Sciences 2,100,000 2,215,000 -
Other Grants 417,700 887,700 -
TOTAL $ 10,017,700 $ 8,202,700 $ -
GRANTS INDEX
27
Approved Paid Transferred/
Cancelled*
SCIENCE EDUCATION
Student Science Enrichment Program $ 1,133,036 $ 1,135,068 $ 24,403
BWF Visiting Professorships
in the Basic Medical Sciences 165,000 160,000 -
BWF Visiting Professorships
in the Microbiological Sciences 55,000 55,000 -
Other Grants 98,317 894,148 -
TOTAL $ 1,451,353 $ 2,244,216 $ 24,403
SCIENCE AND PHILANTHROPY
General $ 162,300 $ 162,300 $ -
Communications 46,000 46,000 -
History of Medicine 15,000 - -
Science Policy 17,500 192,500 -
TOTAL $ 240,800 $ 400,800 $ -
TOTALS $ 45,734,789 $ 34,106,187 $ 5,933,149
GRAND TOTALS† Approved  $ 39,801,640      Paid  $ 34,106,187
* The “Transferred/Cancelled” totals reflect grants made to award recipients who changed institutions, modified the terms of their grant at 
their current institution, or both changed institutions and modified their grant. In these cases, BWF’s policy has been to cancel the remaining
portion of the original grant and, as necessary, approve a new grant. When the award recipient has changed institutions, the new grant is made 
to the new institution; when the award recipient has not moved but has modified the terms, the new grant is made to the current institution.
† To more accurately reflect the total amount that BWF approved in actual “new” dollars during this fiscal year, the “Transferred/Cancelled”
total must be deducted from the “Approved” total.
Key to Grants Index—BWF makes all grants to nonprofit organizations. For most of the programs listed in the following sections, the name 
of the individual on whose behalf the grant is made is listed first, the title of the award recipient’s project is listed second, and the name of the
organization that received the money is listed third. For programs that may have coaward recipients, the award recipients and their organizations
are listed first, followed by the project title. For grants made directly to organizations and not on behalf of an individual, the name of the 
organization is listed first, followed by the title of the project or a brief description of the activity being supported.
Grants Index/Program Summary
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Matthew L. Albert, M.D., Ph.D.
Tumor immunity versus tumor-mediated immunosuppression: 
characterizing the cellular and molecular mechanism of cross-priming
and cross-tolerance
Rockefeller University
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Ravi Allada, M.D.
Molecular and genetic analysis of the circadian rhythm gene Clock
in Drosophila
Northwestern University
Approved $403,146   Paid $210,146
($386,000 of original award to Brandeis University was 
transferred/cancelled)
Matthew P. Anderson, M.D., Ph.D.
Role of T-type calcium channels in thalamic and hippocampal 
rhythmic activity
Massachusetts Institute of Technology
Paid $61,000
Oscar M. Aparicio, Ph.D.
Understanding the relationship of DNA replication to cell cycle 
control of cellular proliferation and chromosomal organization
University of Southern California
Paid $127,500
Nenad Ban, Ph.D.
Determination of the high resolution structure of the large 
ribosomal subunit
($314,000 of original award to Yale University was 
transferred/cancelled)
Jody L. Baron, M.D., Ph.D.
Role of the innate immune system in acute and chronic hepatitis B:
studies in a novel transgenic mouse model of primary HBV infection
University of California-San Francisco School of Medicine
Paid $61,000
Greg J. Bashaw, Ph.D.
Molecular mechanisms of attractive and repulsive axon guidance 
at the midline of Drosophila
University of California-Berkeley
Paid $29,500
Gregory J. Beitel, Ph.D.
Mechanisms that control and execute the cell movements 
and shape changes underlying metazoan morphogenesis
Northwestern University
Paid $115,500
Leonardo Belluscio, Ph.D.
Learning and memory in the mouse olfactory bulb
Duke University Medical Center
Paid $61,000
Guoqiang Bi, Ph.D.
Spatio-temporal specificity of synaptic plasticity at single synaptic 
contacts
University of Pittsburgh School of Medicine
Paid $131,000
($29,500 of original award to the University of California-San Diego
was transferred/cancelled)
David Bilder, Ph.D.
Genetic analysis of epithelial cell architecture
Harvard Medical School
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Mark Bix, Ph.D.
Effector CD4+ T-cell development: evidence for the stochastic generation
and clonal distribution of a combinatorial cytokine repertoire
University of Washington School of Medicine
Paid $118,250
Basic Biomedical Sciences
TOTALS:    Approved  $17,461,480 Paid  $11,631,867 Transferred/Cancelled  $5,312,874
Career Awards in the Biomedical Sciences
Career awards are postdoctoral-faculty bridging awards. During the fiscal year, some award recipients change institutions, modify the terms 
of their award at their current institution, or both change institutions and modify their award. In these cases, BWF’s policy has been to cancel 
the remaining portion of the original award and, as necessary, approve a new award. When the award recipient has changed institutions, the 
new award is made to the new institution; when the award recipient has not moved but has modified the terms, the new award is made to the
current institution. In the following descriptions, the name of the award recipient is listed first, the title of the project is listed second, the award
recipient’s current institution is listed third, and the amount approved or paid to the institution is listed fourth. For award recipients who either
changed institutions or modified their award, the portion of the award paid to the original institution, as well as any portion that was transferred
or cancelled, is listed last, in parentheses. For new award recipients still in the postdoctoral period, the portion of the award intended to cover a
future faculty appointment is listed last, in parentheses.
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Azad Bonni, M.D., Ph.D.
Regulation of glial fate specification in the central nervous system
Harvard Medical School
Paid $124,000
Carrie B. Brachmann, Ph.D.
Using Drosophila as a tool for the study of apoptotic regulation
Washington University School of Medicine
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Edward S. Brodkin, M.D.
Genetic analysis of anxiety-related behaviors in mice
Princeton University
Paid $30,800
Chester W. Brown, M.D., Ph.D.
Understanding the reproductive roles of the activins using an activin
beta B knock-in model
Baylor College of Medicine
Paid $95,000
Michael D. Bulger, Ph.D.
Relationship between organization and function at the mammalian
beta-globin locus
University of Washington School of Medicine
Paid $61,000
Walter R. Burack, M.D., Ph.D.
Analysis of the immunological synapse: a membrane-associated
machine
Washington University School of Medicine
Paid $61,000
Kathleen M. Caron, Ph.D.
Reproductive and cardiovascular effects of the adrenomedullin system
University of North Carolina-Chapel Hill School of Medicine
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
David C. Chan, M.D., Ph.D.
Structural and mechanistic studies of virus-mediated membrane fusion
California Institute of Technology
Paid $115,500
Michael K. Cooper, M.D.
Modulation of sonic hedgehog signal transduction by cholesterol
homeostasis
Johns Hopkins University School of Medicine
Paid $64,500
John D. Crispino, Ph.D.
Functional characterization of hematopoietic transcription factor 
complexes
University of Chicago
Paid $193,000
David E. Cummings, M.D.
Studies of spermatogenesis and metabolism using mutant mice
University of Washington School of Medicine
Paid $118,250
George Q. Daley, M.D., Ph.D.
Probing the pathogenesis of chronic myelogenous leukemia
Massachusetts Institute of Technology
Paid $60,500
Gregory C. DeAngelis, Ph.D.
Neural mechanisms underlying perceptual feature binding
Washington University School of Medicine
Paid $118,250
Paul De Koninck, Ph.D.
Decoding rhythms in the nervous system
University of Laval
Approved $386,000   Paid $65,500
($31,500 of original award to Stanford University Medical Center was
paid; $386,000 of original award to Stanford University Medical
Center was transferred/cancelled)
Abby F. Dernburg, Ph.D.
Chromosome architecture and the fidelity of meiotic segregation
University of California-Berkeley
Paid $65,500
Aaron DiAntonio, M.D., Ph.D.
Genetic analysis of synapse formation, growth, and plasticity
Washington University School of Medicine
Paid $118,250
Ricardo E. Dolmetsch, Ph.D.
Voltage-gated calcium channel signaling in the nucleus
Harvard Medical School
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Kelly S. Doran, Ph.D.
Penetration of the blood-brain barrier in GBS meningitis
University of California-San Diego
Paid $29,500
Charles G. Eberhart, M.D., Ph.D.
Analysis of medulloblastoma pathobiology and response to novel 
therapies using murine transgenic models
Johns Hopkins University School of Medicine
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Peter J. Espenshade, Ph.D.
Molecular mechanism of cholesterol homeostasis in mammalian cells
University of Texas Southwestern Medical Center-Dallas
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
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Miguel Estevez, M.D., Ph.D.
Investigation of a calcium channel related to migraine and epilepsy
in both an invertebrate and a mouse model
University of Pittsburgh Medical Center
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Guowei Fang, Ph.D.
Mechanism of spindle assembly checkpoint control
Stanford University Medical Center 
Paid $115,500
Kathryn M. Ferguson, Ph.D.
Structural basis for erbB receptor activation by epidermal growth 
factor agonists and neuregulin
University of Pennsylvania School of Medicine
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Elizabeth A. Finch, Ph.D.
Postsynaptic calcium signaling by inositol trisphosphate in neuronal
dendrites
Emory University School of Medicine
Paid $193,000
Reiko Maki Fitzsimonds, Ph.D.
Distributed properties of synaptic plasticity in neural networks
Yale University School of Medicine
Paid $60,500
Robert C. Flaumenhaft, M.D., Ph.D.
SNARE proteins in platelet alpha-granule secretion
Harvard Medical School
Paid $127,500
Nicholas R. Gaiano, Ph.D.
Neural stem cells in the mammalian forebrain: the roles of Notch 
and FGF signaling
New York University School of Medicine
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Timothy P. Galitski, Ph.D.
Genetic networks
Massachusetts Institute of Technology
Approved $63,000
Jeffrey S. Glenn, M.D., Ph.D.
Prenylation and viral assembly
Stanford University School of Medicine
Paid $118,250
Joshua I. Gold, Ph.D.
Neural basis of perceptual-decision formation
University of Washington School of Medicine
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Patrick A. Grant, Ph.D.
Analysis of histone acetyltransferase/transcriptional adaptor complexes
in the regulation of gene expression
University of Virginia Health Sciences Center
Paid $124,000
Michael Graziano, Ph.D.
From eye to hand: sensory-motor integration in the primate brain
Princeton University
Paid $97,000
Matthias Gromeier, M.D.
Principles of polio neuropathies: exploiting poliovirus of brain cancer
Duke University Medical Center
Paid $124,000
Jay T. Groves, Ph.D.
Studies of cell recognition and signaling with micropatterned lipid
membranes
University of California-Berkeley
Paid $29,500
Karen J. Guillemin, Ph.D.
Genetic and cellular basis of Helicobacter pylori-associated 
malignancies
University of Oregon
Approved $386,000   Paid $65,500
Carrie Haskell-Luevano, Ph.D.
Determination of the physiological and pharmacological role 
of the brain-specific agouti-related transcript
University of Florida College of Pharmacy
Paid $121,000
Zhigang He, M.D., Ph.D.
Signaling mechanisms mediating the repulsive effects on developing
and regenerating axons
Harvard Medical School
Paid $127,500
Victoria G. Herman, Ph.D.
Defining the molecular code for synaptic target selection
University of California-Los Angeles School of Medicine
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Joel N. Hirschhorn, M.D., Ph.D.
Genetic analysis of complex endocrine disorders
Harvard Medical School
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Michael D. Hogarty, M.D.
BIN1: a MYCN interacting neuroblastoma suppressor
University of Pennsylvania School of Medicine
Paid $29,500
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Lora V. Hooper, Ph.D.
Molecular analysis of commensal host-microbial interactions 
in the intestine
Washington University School of Medicine
Paid $61,000
Jennifer S. Hovis, Ph.D.
Understanding lipid and protein interactions at the molecular level 
in model cell membranes
Stanford University
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Xianxin Hua, M.D., Ph.D.
Identification and characterization of novel components in the TGF-ß
signaling pathway 
University of Pennsylvania Health System
Approved $357,500   Paid $178,750
($419,100 of original award to the Massachusetts Institute 
of Technology was transferred/cancelled) 
Alan J. Hunt, Ph.D.
Role of microtubule dynamics in mitotic chromosome movement
University of Michigan Health System
Paid $60,500
Jeffry S. Isaacson, Ph.D.
Biophysical properties of presynaptic terminals in the central 
nervous system
University of California-San Diego School of Medicine
Paid $89,100
Akiko Iwasaki, Ph.D.
Defining the mechanism of immune induction and effector function 
in the female genital mucosa
Yale University School of Medicine
Paid $127,500
Ursula H. Jakob, Ph.D.
Structural and functional characterization of new heat shock proteins
University of Michigan Health System
Paid $29,500
James D. Jontes, Ph.D.
Role of protocadherins in neural development studied in living zebra
fish embryos
Stanford University
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
David K. R. Karaolis, Ph.D.
Pathogenicity islands in the emergence of epidemic and pandemic
cholera
University of Maryland-Baltimore School of Medicine
Paid $118,250
Suzanne L. Kirby, M.D., Ph.D.
Proliferative advantage for therapeutic bone marrow
University of North Carolina-Chapel Hill School of Medicine
Paid $60,500
Laura J. Knoll, Ph.D.
Molecular genetic approaches to investigate developmental regulation
in Toxoplasma gondii
Stanford University Medical Center
Paid $31,500
William R. Kobertz, Ph.D.
Molecular interactions of the lipid-exposed surfaces of integral 
membrane proteins
University of Massachusetts Medical School
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Scott C. Kogan, M.D.
Use of a transgenic mouse model of acute promyelocytic leukemia 
to elucidate disease pathogenesis and to improve therapy
University of California-San Francisco School of Medicine
Paid $118,250
William L. Kraus, Ph.D.
Biochemical analysis of estrogen receptor activity with chromatin 
templates
Cornell University
Paid $121,000
Bruce T. Lahn, Ph.D.
Systematic investigation of mammalian spermatogenesis
University of Chicago
Paid $127,500
Benhur Lee, M.D.
HIV-1 coreceptors and their role in HIV-associated hematopoietic 
dysfunction
University of California-Los Angeles
Approved $29,500   Paid $160,500
($29,500 of original award to the University of Pennsylvania 
School of Medicine was transferred/cancelled)
Jeh-Ping Liu, Ph.D.
Molecular mechanisms in neural crest specification
University of Virginia Health System
Approved $357,500   Paid $121,000
($357,500 of original award to the Columbia University College 
of Physicians and Surgeons was transferred/cancelled)
Hiten D. Madhani, M.D., Ph.D.
Specificity of signal transduction during dimorphic development 
of yeast
University of California-San Francisco
Paid $118,250
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Mala S. Mahendroo, Ph.D.
Characterization of fecundity and parturition defects in mice deficient
in steroid 5 alpha-reductase type 1
University of Texas Southwestern Medical Center-Dallas
Paid $118,250
Zachary F. Mainen, Ph.D.
Optical studies of synaptic plasticity mechanisms
Cold Spring Harbor Laboratory
Paid $118,250
Kelsey C. Martin, M.D., Ph.D.
Communication between the synapse and the nucleus during 
long-lasting synaptic plasticity
University of California-Los Angeles School of Medicine
Paid $118,250
Robert Menard, M.D., Ph.D.
Genetic analysis of malaria sporozoite virulence
($121,000 of award to New York University Medical Center was 
transferred/cancelled)
Chandra Mohan, M.D., Ph.D.
B-cell tolerance and humoral autoimmunity
University of Texas Southwestern Medical Center-Dallas
Paid $121,000
Kelle H. Moley, M.D.
Glucose transport and apoptosis in blastocysts from diabetic mice
Washington University School of Medicine
Paid $115,500
Inke S. Nathke, Ph.D.
Role of APC/catenin complexes in colon cancer
University of Dundee
Paid $60,500
James M. Olson, M.D., Ph.D.
NeuroD abrogation in neuroblastoma
University of Washington School of Medicine
Paid $178,750
Karen M. Ottemann, Ph.D.
Chemotaxis in Helicobacter pylori and its role in pathogenesis
University of California-Santa Cruz
Paid $178,750
Martin S. Pavelka Jr., Ph.D.
Biosynthesis of the mycobacterial cell wall
University of Rochester
Paid $121,000
Thomas T. Perkins, Ph.D.
Measurements of single DNA-based molecular motors
Stanford University
Paid $31,500
Samuel J. Pleasure, M.D., Ph.D.
Molecular control of cell fate in the dentate gyrus
University of California-San Francisco School of Medicine 
Paid $127,500
Salman T. Qureshi, M.D.
Genetic analysis of innate resistance to bacterial pathogens
Yale University School of Medicine
Approved $477,400   Paid $89,100
($477,400 of original award to the McGill University Faculty 
of Medicine was transferred/cancelled)
Jill Rafael, Ph.D.
Role of muscle proteins in synaptic structure and neuromuscular 
disease
Ohio State University School of Medicine
Paid $127,500
Matthew Redinbo, Ph.D.
Structural and functional characterization of human topoisomerase I
and the Werner syndrome helicase
University of North Carolina-Chapel Hill
Paid $127,500
David J. Robbins, Ph.D.
Dissecting the hedgehog signal transduction pathway
University of Cincinnati College of Medicine
Paid $60,500
Douglas N. Robinson, Ph.D.
Studies of the mechanisms of cytokinesis using Dictyostelium
Stanford University School of Medicine
Paid $61,000
Aimee K. Ryan, Ph.D.
Analysis of inductive events responsible for specification and 
differentiation of the anterior pituitary gland
McGill University
Approved $357,500   Paid $178,750
($357,500 of original award to the University of California-San Diego
was transferred/cancelled)
Bernardo L. Sabatini, M.D., Ph.D.
Role of localized biochemical signaling in the regulation of synaptic
function and spine morphogenesis
Cold Spring Harbor Laboratory
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Maria A. Schumacher, Ph.D.
Structural biology of cell growth, development, and regulation
Oregon Health Sciences University
Approved $63,000   Paid $63,000
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Nirao M. Shah, Ph.D.
Genetic analysis of neural circuits mediating sexually dimorphic
behaviors in mammals
Columbia University College of Physicians and Surgeons
Paid $61,000
Krishna V. Shenoy, Ph.D.
Early reach plans in posterior parietal cortex
California Institute of Technology
Paid $31,500
Stanford University
Paid $65,500
Elaine K. Sia, Ph.D.
Analysis of yeast mutants with altered simple repeat stability
University of Rochester
Paid $115,500
Upinder Singh, M.D.
Transcriptional control in Entamoeba histolytica
Stanford University School of Medicine
Paid $91,300
Barry P. Sleckman, M.D., Ph.D.
Lineage-specific regulation of T cell receptor beta rearrangement
Washington University School of Medicine
Paid $60,500
Douglas E. Smith, Ph.D.
Single molecular studies of viral DNA packaging
University of California-Berkeley
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Leonidas Stefanis, M.D.
Proteases in neuronal cell death
Columbia University College of Physicians and Surgeons
Paid $60,500
Theodore S. Steiner, M.D.
Isolation and characterization of an interleukin 8 releasing protein
from enteroaggregative Escherichia coli
University of British Columbia Faculty of Medicine
Approved $386,000   Paid $131,000
($483,500 of original award to the University of Virginia Health
Sciences Center was transferred/cancelled)
Xin Sun, Ph.D.
Understanding the endoderm in organogenesis and regeneration
University of California-San Francisco
Approved $59,000   Paid $29,500
($386,000 approved for future faculty appointment)
Surachai Supattapone, M.D., D.Phil.
Structure and biology of a soluble prion
Dartmouth Medical School
Approved $357,500   Paid $60,500
($357,500 of original award to the University of California-San Francisco
School of Medicine was transferred/cancelled)
Roger B. Sutton, Ph.D.
Biophysical and structural investigation of Ca+2 in neurotransmitter
release
Stanford University
Paid $90,500
Suzanne J. Szabo, Ph.D.
T-bet, a novel t-box transcription factor that directs T-helper cell 
type 1 lineage commitment
Harvard School of Public Health
Paid $61,000
Sarah A. Tishkoff, Ph.D.
Molecular sequence variation in G6PD and its role in malarial 
resistance
University of Maryland-College Park
Approved $357,500   Paid $178,750
($357,500 of original award to Pennsylvania State University was
transferred/cancelled)
Heidi A. Tissenbaum, Ph.D.
Genetic and molecular analysis of genes controlling longevity 
in Caenorhabditis elegans
University of Massachusetts Medical School
Approved $386,000   Paid $65,500
Stephen H. Tsang, M.D., Ph.D.
Unraveling genetic pathways leading to cell death in mice lacking
the gamma subunit of the cGMP phosphodiesterase
University of California-Los Angeles School of Medicine
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Katharine S. Ullman, Ph.D.
Biochemical dissection of RNA export using in vitro nuclear 
reconstitution
University of Utah
Paid $60,500
James A. Waddle, Ph.D.
Generation of markers and methods to study asymmetric cell divisions
in living Caenorhabditis elegans embryos
University of Texas Southwestern Medical Center-Dallas
Paid $60,500
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Johannes Walter, Ph.D.
Characterization of eukaryotic replication initiation factors using 
a soluble, cell-free system
Harvard Medical School
Paid $118,250
Michael M. Wang, M.D., Ph.D.
Estrogen receptors and neuroprotection against excitotoxic injury
Johns Hopkins University School of Medicine
Paid $61,000
William A. Weiss, M.D., Ph.D.
Transgenic model for neuroblastoma
University of California-San Francisco School of Medicine
Paid $60,500
Anthony P. West, Ph.D.
Identification of the natural ligand of methuselah, a Drosophila
GPCR associated with extended lifespan 
California Institute of Technology
Approved $122,000   Paid $29,500
($386,000 approved for future faculty appointment)
Carmen J. Williams, M.D., Ph.D.
Signal transduction mechanisms during mouse egg activation
University of Pennsylvania School of Medicine
Paid $118,250
Michael B. Yaffe, M.D., Ph.D.
Scaffolding and chaperone proteins in signal transduction: 
14-3-3 regulation of mitosis and programmed cell death
Massachusetts Institute of Technology
Approved $386,000   Paid $131,000
Harvard Medical School
Approved $31,500   Paid $31,500
($386,000 of original award to Harvard Medical School was 
transferred/cancelled)
Cassian Yee, M.D.
Adoptive immunotherapy of melanoma using T cells specific 
for potential tumor rejection antigens
University of Washington School of Medicine
Paid $60,500
Deborah L. Yelon, Ph.D.
Patterning during organogenesis: genetic analysis of cardiac chamber
formation
New York University School of Medicine
Paid $127,500
Yanping Zhang, Ph.D.
ARF-MDM-p53 tumor suppression pathway
($92,500 of original award to the University of North Carolina-Chapel
Hill School of Medicine was transferred/cancelled)
SUBTOTALS: Approved  $14,949,046
Paid  $9,641,446 
Transferred/Cancelled  $4,554,500
Louis J. Muglia, M.D., Ph.D.
Glucocorticoid effects of T cell development
Washington University School of Medicine
Approved $24,044
Matthew Redinbo, Ph.D.
Structural genomics: high-throughput methods and human 
nuclear receptors
University of North Carolina-Chapel Hill
Approved $19,520
Upinder Singh, M.D.
Genomic approaches to investigating Entamoeba histolytica
pathogenesis
Stanford University School of Medicine
Approved $25,000
SUBTOTALS: Approved $68,564
Career Awards Collaborative Grant
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Hitchings-Elion Fellowships
Michael W. Black, Ph.D.
Secretion-dependent regulation of ribosome synthesis 
in Saccharomyces cerevisiae
Medical Research Council
Paid $32,250
Tamara Caspary, Ph.D.
Identification and characterization of novel genes involved 
in mammalian sex determination
Memorial Sloan-Kettering Cancer Center
Approved $122,246   Paid $62,246
($288,000 of original grant to the National Institute for Medical
Research was transferred/cancelled)
($168,000 approved for future faculty appointment)
John W. R. Copeland, Ph.D.
Activation of SRF actin remodeling proteins
Imperial Cancer Research Fund
Paid $59,000
Aaron R. Dinner, Ph.D.
Molecular mechanism of free radical oxidative DNA damage
University of Oxford
Paid $23,125
University of California-Berkeley
Paid $27,750
Francine Durocher, Ph.D.
Identifying common low-penetrance genes and gene-environment
interactions in breast cancer
University of Cambridge
Approved $27,500
John T. Finn, Ph.D.
Cell-cycle control of cell number in the retina
($44,100 of original award to the University College London School 
of Medicine was transferred/cancelled)
Reuben S. Harris, Ph.D.
Delineation of the mechanisms of immunoglobulin gene hypermutation
Medical Research Council
Paid $60,000
Alan J. Herr, Ph.D.
Probing the pathway of RNA-mediated defense with viral suppressor
genes
Sainsbury Laboratory
Paid $54,500
Susan C. Hockings, Ph.D.
Biochemical and biophysical properties of an RNA binding protein
from Drosophila
Washington University School of Medicine
Approved $58,713   Paid $34,213
Steven L. Kazmirski, Ph.D.
Structural and dynamical characterization of the folding pathway 
of the oligomerization domain of p53
University of Cambridge
Approved $12,000   Paid $12,000
($223,500 of original award to the University of Cambridge was 
transferred/cancelled)
Steven L. Kazmirski, Ph.D.
Computational analysis of ATP-dependent motor proteins that are
involved in the loading of DNA polymerase clamps onto DNA during
DNA replication
Rockefeller University
Approved $55,500   Paid $27,750
($168,000 approved for future faculty appointment)
Kenro Kusumi, Ph.D.
Notch pathway patterning of the mammalian brain and skeleton
University of Pennsylvania School of Medicine
Approved $195,750   Paid $27,750
($195,750 of original award to the National Institute for Medical
Research was transferred/cancelled)
David J. Rossi, Ph.D.
Mechanisms of ischemia-induced excitotoxicity
University College London
Paid $55,500
Kristin C. Scott, Ph.D.
Ectopic silencing in fission yeast
Case Western Reserve University
Approved $51,700   Paid $51,700
Dean G. Tang, M.D., Ph.D.
Role of cell-cycle components in timing the oligodendrocyte precursor
cell differentiation and senescence
University of Texas M. D. Anderson Cancer Center
Approved $51,500   Paid $27,000
University College London
Approved $3,600   Paid $3,600
SUBTOTALS: Approved  $914,509
Paid  $558,384 
Transferred/Cancelled  $751,350
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Ryan B. Case, Ph.D.
Biophysical analysis of 13S Xenopus condensin
University of California-Berkeley
Paid $41,000
Su L. Chiang, Ph.D.
Genetic approaches to identifying mycobacterial virulence genes
Harvard School of Public Health
Paid $41,000
Douglas J. Guarnieri, Ph.D.
Characterization of a Drosophila neuropeptide receptor involved 
in ethanol-induced behavior
University of California-San Francisco
Paid $41,000
Chau V. Huynh, Ph.D.
Intracellular interaction of Leishmania amazonensis with host 
histocompatibility complex (MHC) class II molecules
Yale University School of Medicine
Paid $41,000
Diane McFadden, Ph.D.
Characterization of O-acetylated carbohydrate epitopes 
on Cryptococcus neoformans
Albert Einstein College of Medicine
Approved $123,000   Paid $41,000
Peri Tate, Ph.D.
Heterochromatin proteins old and new
University of California-Berkeley
Paid $41,000
Scott T. Walsh, Ph.D.
Molecular recognition studies of human placental lactogen
University of Chicago
Approved $123,000   Paid $41,000
Robert T. Wheeler, Ph.D.
Creating a diversity of cell surface adhesin molecules in fungal 
pathogenesis
Massachusetts Institute of Technology
Approved $123,000   Paid $41,000
SUBTOTALS: Approved  $369,000
Paid  $328,000
Obstetrics and Gynecology Research Fellowships
Life Sciences Research Fellowships
These fellowships are administered in partnership with the Life Sciences Research Foundation. BWF awards the primary grant to the foundation,
which distributes the funds to the individual awardees. 
Angeles A. Alvarez, M.D.
Duke University Medical Center
Regulation of angiogenesis in ovarian cancer and development 
of antiangiogenesis therapy
Approved $153,000   Paid $51,000
Oliver Dorigo, M.D.
University of California-Los Angeles School of Medicine
Development of a novel gene transfer system using gutless hybrid
adeno-Epstein-Barr virus for prolonged transgene expression
Paid $61,000
Karen H. Lu, M.D.
Harvard Medical School
Genetic alterations in ovarian cancers associated with germ line
BRCA1 mutations
Paid $48,000
Douglas A. Woelkers, M.D.
University of Pittsburgh School of Medicine
Oxidative stress and preeclampsia
Paid $24,000
SUBTOTALS: Approved  $153,000
Paid  $184,000
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Nancy Anderson
Drawing, photography, and the microscope in 19th century studies 
of the cell
University of Michigan-Ann Arbor
Approved $2,075   Paid $2,075
Kathryn H. Arehart, Ph.D.
Models and auditory perception in listeners with cochlear hearing
loss: theoretical development and clinical applications
University of Colorado-Boulder
Approved $5,770   Paid $5,770
Robert J. Brown
Britain and the Spanish influenza epidemic of 1918-19
Syracuse University
Approved $4,000   Paid $4,000
Jaime Caro, M.D.
Angiogenic and oncogenic roles of HIF-1 activation
Thomas Jefferson University Jefferson Medical College
Approved $14,800   Paid $14,800
John R. G. Challis, Ph.D., D.Sc.
Effects of glucocorticoids on placental and fetal development: 
implications for adult disease
University of Toronto Faculty of Medicine
Approved $7,600   Paid $7,600
Estelle Cohen, Ph.D.
Reproduction and the state in Britain 1850-1930, with particular 
reference to the work of Frances Hoggan, M.D. (1843-1927)
Harvard University
Approved $3,000
Bryan R. Cullen, Ph.D.
Design and analysis of improved gene therapy vectors based 
on foamy virus
Duke University Medical Center
Approved $9,454   Paid $9,454
Elisabeth M. Fine, Ph.D.
Concurrent recording of retinal and eye location in patients with 
age-related macular degeneration
Harvard Medical School
Approved $4,400   Paid $4,400
Darrell R. Galloway, Ph.D.
Development of a DNA-based vaccine against anthrax
Ohio State University
Approved $6,750   Paid $6,750
Ellen L. Goode, Ph.D.
Impact of estrogen metabolism and DNA repair polymorphisms 
on survival in a population-based sample of breast cancer patients
University of Washington School of Public Health and Community
Medicine
Approved $10,000   Paid $10,000
Jacqueline M. Hibbert, Ph.D.
Stable isotope method to measure hemoglobin synthesis rate
Morehouse School of Medicine
Approved $5,630   Paid $5,630
David L. Hurley, Ph.D.
Developmental characterization of pituitary-specific transcription 
factors in the growth hormone-deficient dwarf rat
Tulane University
Approved $12,543   Paid $12,543
Grants Index/Basic Biomedical Sciences 
BWF Research Travel Grants
*Grants are related to history of medicine.
History of Medicine Travel Grants
Jake W. Spidle, Ph.D.
Take two aspirin and call me in the morning: a survey history 
of aspirin
University of New Mexico
Approved $4,224   Paid $4,224
Bruce H. Weber, Ph.D.
A biography of Dr. Peter Dennis Mitchell (1920-92), 
Nobel Laureate (1978)
California State University-Fullerton
Approved $1,300   Paid $1,300
SUBTOTALS: Approved  $5,524
Paid  $5,524
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Brant E. Isakson
Mechanisms of peptide inhibition of gap junctional intercellular 
communication
University of Wyoming
Approved $4,400   Paid $4,400
Mei-ling A. Joiner, Ph.D.
Behavioral analysis of Drosophila mutants with altered electroretinograms
University of Iowa
Approved $10,640   Paid $10,640
Bernadette Kalman, M.D., Ph.D.
Genetics of multiple sclerosis
MCP Hahnemann University School of Medicine
Approved $12,974   Paid $12,974
Mark S. Kindy, Ph.D.
Identification of the serum amyloid A receptor: role in inflammation
University of Kentucky School of Medicine
Approved $9,480
Anjan Kowluru, Ph.D.
Novel roles for G-proteins in the apoptotic demise of the pancreatic
beta cell: relevance to the pathophysiology of diabetes
Wayne State University
Approved $4,750   Paid $4,750
May H. Lesser
Study of the surgeon who performed the first liver transplantation 
in the United Kingdom
Tulane University School of Medicine
Approved $700   Paid $700
Stephen R. Lyle, M.D., Ph.D.
Role of MLK-3 in the proliferative potential of human hair follicle 
stem cells
Harvard Medical School
Paid $5,800
Elias R. Melhem, M.D.
In vivo study of white matter fiber tract myelination and orientation 
in neonatal brain using diffusion tensor magnetic resonance imaging
Johns Hopkins University School of Medicine
Approved $7,180   Paid $7,180
Morton W. Miller, Ph.D.
Ultrasound-induced hyperthermic teratogenesis
University of Rochester School of Medicine and Dentistry
Paid $3,335
Robert V. Miller, Ph.D.
Exploring the molecular biology and ecology of antibiotic resistance 
in Antarctic bacteria
Oklahoma State University
Approved $14,000   Paid $14,000
Ravi Murthy, M.D.
Subintimal angioplasty: application to critical ischemia in limb salvage
in the end-stage renal disease population
University of Maryland Medical Center
Paid $2,600
Felicia V. Nowak, M.D., Ph.D.
Subcellular localization of the preoptic regulatory peptides
($7,024 of original award to Saint Louis University Health Sciences
Center was transferred/cancelled)
Ike S. Okosun, Ph.D.
Intrauterine factors and adult diseases
Mercer University School of Medicine
Approved $5,300   Paid $5,300
Robert C. Olby, Ph.D.
Crick’s Cambridge years
University of Pittsburgh
Approved $2,000   Paid $2,000
Michael B. A. Oldstone, M.D.
Molecular anatomy of the interaction of viral glycoprotein with 
its receptor
Scripps Research Institute
Approved $13,500   Paid $13,500
Stephen M. Patterson, Ph.D.
Influence of multiple risk factors for hypertension and fluid hydration
on hemorheology reactivity
Ohio University
Paid $3,416
Samuel L. Perkins
Expression of C1fB on the surface of Staphylococcus aureus
Texas A&M University
Approved $3,900   Paid $3,900
Carol J. Phelps, Ph.D.
Differentiation of pituitary-regulation neurons in rodent models 
of hypothalamic or pituitary growth hormone deficiency
Tulane University School of Medicine
Approved $12,543   Paid $12,543
Carla M. Pugh, M.D.
Biomedical computations for a simulation tool: indications for skills
assessment and the training of health care professionals
Stanford University
Approved $4,800   Paid $4,800
Grants Index/Basic Biomedical Sciences 
39
Grants Index/Basic Biomedical Sciences 
David B. Sacks, M.B., Ch.B. 
Role of IQGAP1 and calmodulin in regulating the function of the 
Rho GTPases
Harvard Medical School
Approved $12,000   Paid $12,000
Jason K. Sello
Understanding the regulation of morphological differentiation 
and antibiotic biosynthesis in Streptomyces species
Harvard University
Approved $5,200   Paid $5,200
Thomas N. Seyfried, Ph.D.
In utero therapy for ganglioside storage disease
Boston College
Paid $5,100
L. David Sibley, Ph.D.
Genetic mapping in Toxoplasma
Washington University School of Medicine
Paid $4,125
Shanthi K. Sinniah, Ph.D.
Using chemical force microscopy to study receptor-ligand binding
model systems
Calvin College
Approved $13,500   Paid $13,500
Patrick J. Skelly, Ph.D.
Inhibition of protease gene expression in schistosomes by RNA-mediated
interference
Harvard School of Public Health
Approved $7,800   Paid $7,800
Philip D. Sloane, M.D.
Behavior mapping as a quality of life indicator for Alzheimer’s disease
University of North Carolina-Chapel Hill School of Medicine
Approved $3,350   Paid $3,350
Stephen D. Smith
Perception without awareness in depressed populations: 
an fMRI study 
University of Waterloo
Approved $6,000   Paid $6,000
Donald J. Tipper, Ph.D.
Translocation of the receptor for pathogenic Escherichia coli to host cells
University of Massachusetts Medical School
Paid $12,280
Sandor Vajda, Ph.D.
Iterative approach to protein-protein docking
Boston University
Approved $6,078   Paid $6,078
Geoffrey B. West, Ph.D.
Universal scaling laws in biology
University of New Mexico
Approved $10,000   Paid $10,000
John A. White, Ph.D.
Effects of molecular fluctuations on analog and digital signaling pathways
in the nervous system
Boston University
Approved $10,520   Paid $10,520
Michael M. Zeineh
Visualizing the activity of the human hippocampus during memory
experiments
University of California-Los Angeles School of Medicine
Approved $4,850   Paid $4,850
Sheryl S. Zimmerman, Ph.D.
Behavior mapping as a quality of life indicator for Alzheimer’s disease
University of North Carolina-Chapel Hill School of Medicine
Approved $3,350   Paid $3,350
SUBTOTALS: Approved  $274,837
Paid  $299,013
Transferred/Cancelled  $7,024
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American Association for the Advancement of Science
Support for a Web-based program to help young research scientists
improve their interviewing skills
Approved $5,000   Paid $5,000
American Association for the Advancement of Science
Support for the Career Development Center, a Web site for young
research scientists
Approved $147,000   Paid $147,000
American Association for the Advancement of Science
Support for Next Wave Web site promotions
Approved $30,000   Paid $30,000
American Association of Obstetricians and Gynecologists
Foundation
Support for evaluating and restructuring a foundation fellowship 
program
Approved $20,000   Paid $20,000
American Society of Andrology
Support for postdoctoral travel awards to the seventh International
Congress of Andrology
Approved $3,000   Paid $3,000
Association of American Medical Colleges
Support for postdoctoral fellows to attend a meeting of the association’s
Group on Graduate Research, Education, and Training 
Paid $11,500
Commission on Professionals in Science and Technology
Support for general activities
Approved $1,000   Paid $1,000
Marine Biological Laboratory
Support for the course titled “Frontiers in Reproduction”
Approved $384,375   Paid $164,125
National Academy of Sciences
Support for a convocation on enhancing the postdoctoral experience
Approved $20,000   Paid $20,000
Society for the Study of Reproduction
Support for postdoctoral trainees to attend the society’s annual meetings
Approved $5,000   Paid $11,000
University of California-San Francisco School of Medicine
Support for the Reproductive Scientist Development Program
Paid $160,000
University of North Carolina-Chapel Hill School of Medicine
Support for travel of speakers attending the University of North
Carolina Postdoc Association meeting
Approved $1,000   Paid $1,000
University of Pennsylvania School of Medicine
Support for planning and administering the “Frontiers in Reproduction”
course
Approved $110,625   Paid $41,875
SUBTOTALS: Approved  $727,000
Paid  $615,500
Other Grants
In addition to making competitive awards, BWF makes noncompetitive grants for activities that are closely related to our major focus areas.
These grants are intended to enhance the general environment for research in the targeted areas.
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Alan A. Aderem, Ph.D.
Macrophage responses to Leishmania infection
University of Washington School of Medicine
Approved $425,000   Paid $127,500
($382,500 of original award to the University of Washington School 
of Medicine was transferred/cancelled)
Norma W. Andrews, Ph.D.
Role of lysosome exocytosis in the cell invasion mechanism 
of Trypanosoma cruzi
Yale University School of Medicine
Paid $80,000
Paul J. Brindley, Ph.D.
Schistosome transgenesis
Tulane University School of Public Health and Tropical Medicine
Approved $425,000   Paid $42,500
Daniel E. Goldberg, M.D., Ph.D.
Hemoglobin metabolism in Plasmodium falciparum
Washington University School of Medicine
Paid $80,000
Patricia J. Johnson, Ph.D.
Investigation of potential chemotherapeutic targets and the pathogenesis
of the human-infective parasite Trichomonas vaginalis
University of California-Los Angeles School of Medicine
Paid $80,000
Scott M. Landfear, Ph.D.
Biology of membrane transporters in Leishmania parasites
Oregon Health Sciences University School of Medicine
Paid $80,000
James H. McKerrow, M.D., Ph.D.
Parasite proteases: analysis of structure-function relationships 
and structure-based drug design
University of California-San Francisco School of Medicine
Paid $60,000
Marc Ouellette, Ph.D.
Functional genomics of drug resistance in Leishmania
Laval University Faculty of Medicine 
Approved $425,000   Paid $42,500
Edward J. Pearce, Ph.D.
Role of the TGF-beta superfamily in host signaling to schistosomes 
Cornell University College of Veterinary Medicine
Paid $85,000
William Petri Jr., M.D., Ph.D. 
Adherence and cytolysis by Entamoeba histolytica
University of Virginia Health Sciences Center
Paid $60,000
Margaret A. Phillips, Ph.D.
Design of inhibitors for Trypanosoma brucei ornithine decarboxylase
using a combination of structure-based approaches and combinatorial
chemistry
University of Texas Southwestern Medical Center-Dallas
Paid $85,000
David S. Roos, Ph.D.
Exploring the function of the apicomplexan plastid
University of Pennsylvania
Paid $20,000
L. David Sibley, Ph.D.
Molecular pathogenesis in toxoplasmosis
Washington University School of Medicine
Paid $85,000
Samuel L. Stanley, M.D.
Pathways for amebic induction of inflammation and programmed 
cell death
Washington University School of Medicine
Paid $85,000
Elisabetta Ullu, Ph.D.
Molecular analysis of the nucleus in Trypanosoma brucei
Yale University School of Medicine
Paid $60,000
SUBTOTALS: Approved  $1,275,000
Paid  $1,072,500
Transferred/Cancelled  $382,500
Infectious Diseases  
TOTALS: Approved  $4,823,072    Paid  $6,100,231    Transferred/Cancelled  $595,872
Scholar Awards in Molecular Parasitology
Grants Index/Infectious Diseases  
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Cornelis J. Beckers, Ph.D.
Role of cytoplasmic calcium in the regulation of motility and host 
cell invasion by Toxoplasma gondii
University of Alabama-Birmingham School of Medicine
Paid $32,500
Vivian M. Bellofatto, Ph.D.
Molecular analysis of trypanosome gene transcription
University of Medicine and Dentistry of New Jersey
Paid $32,500
Michael Cappello, M.D.
Molecular pathogenesis of hookworm anemia
Yale University School of Medicine
Paid $70,000
Vernon B. Carruthers, Ph.D.
Defining the proteome of toxoplasma secretory proteins
Johns Hopkins University School of Public Health
Approved $210,000   Paid $35,000
Daniel J. Eichinger, Ph.D.
Control of encystation-specific gene expression in Entamoeba
New York University School of Medicine
Paid $70,000
Theresa Gaasterland, Ph.D.
Comparative genome annotation of Plasmodium falciparum, Leishmania
major, and Trypanosoma brucei
Rockefeller University
Paid $70,000
Stuart J. Kahn, M.D.
Analysis of the naive T-cell response to the surface glycoprotein 
superfamily of Trypanosoma cruzi
University of Washington School of Medicine
Paid $32,500
Kami Kim, M.D.
Signaling pathways and Toxoplasma gondii differentiation
Albert Einstein College of Medicine
Paid $32,500
Silvia N. J. Moreno, Ph.D.
Pyrophosphate metabolism in Toxoplasma gondii
University of Illinois at Urbana-Champaign College 
of Veterinary Medicine
Paid $70,000
Martin Olivier, Ph.D.
Role of the macrophage protein tyrosine phosphatase SHP-1 
in Leishmania pathogenesis
Laval University Faculty of Medicine
Paid $32,500
Barbara Papadopoulou, Ph.D.
Functional genomics of stage-specific gene expression 
in the kinetoplastid protozoan Leishmania donovani
Laval University Faculty of Medicine 
Approved $210,000   Paid $35,000
Christian Tschudi, Ph.D.
Function of cis-splicing in trypanosome RNA
Yale University School of Medicine
Paid $70,000
Gary E. Ward, Ph.D.
Chemical genetic approach to the study of host cell invasion 
by Toxoplasma gondii
University of Vermont College of Medicine
Approved $210,000   Paid $35,000
SUBTOTALS: Approved  $630,000
Paid  $617,500
Grants Index/Infectious Diseases  
Martin Bard, Ph.D.
Characterization of new target sites for antifungal intervention 
in the Candida albicans ergosterol pathway
Indiana University-Purdue University at Indianapolis
Paid $85,000
Judith Berman, Ph.D.
Use of Saccharomyces cerevisiae to study molecular mechanisms 
of Candida albicans pathogenicity
University of Minnesota
Paid $80,000
William A. Fonzi, Ph.D.
Environmental signals and virulence of Candida albicans
Georgetown University Medical Center
Paid $60,000
William E. Goldman, Ph.D.
Probing the parasitic lifestyle of Histoplasma capsulatum
Washington University School of Medicine
Paid $60,000
Joseph Heitman, M.D., Ph.D.
Signal transduction pathways regulating virulence 
of Cryptococcus neoformans
Duke University Medical Center
Paid $80,000
Alexander D. Johnson, Ph.D.
Analysis of a mating-type-like locus in Candida albicans
University of California-San Francisco School of Medicine
Paid $40,000
Elizabeth J. Keath, Ph.D.
Novel molecular and DNA vaccine approaches 
to Histoplasma capsulatum
Saint Louis University
Paid $80,000
Bruce Klein, M.D.
Genetic immunization against pathogenic fungi
University of Wisconsin Medical School
Paid $60,000
James W. Kronstad, Ph.D.
Temperature-regulated and infection-regulated gene expression 
in Cryptococcus neoformans
University of British Columbia
Paid $85,000
Stuart M. Levitz, M.D.
Use of molecular biology to identify Cryptococcus neoformans
antigens that stimulate cell-mediated immunity
Boston University School of Medicine
Paid $80,000
Aaron P. Mitchell, Ph.D.
Analysis of the Candida CaRIM transduction pathway
Columbia University College of Physicians and Surgeons
Paid $80,000
Carol S. Newlon, Ph.D.
Analysis of chromosome structure and function in the pathogenic
basidiomycete Cryptococcus neoformans
University of Medicine and Dentistry of New Jersey
Approved $425,000   Paid $42,500
Peter A. B. Orlean, Ph.D.
Glycolipid anchoring of protein and wall biogenesis in fungal
pathogens
University of Illinois at Urbana-Champaign
Paid $80,000
Michael P. Snyder, Ph.D.
Analysis of morphogenic differentiation in Candida albicans
Yale University
Paid $85,000
Paula Sundstrom, Ph.D.
Global regulatory circuits and candidiasis
Ohio State University School of Medicine
Paid $85,000
SUBTOTALS: Approved  $425,000
Paid  $1,082,500
Scholar Awards in Molecular Pathogenic Mycology
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J. Andrew Alspaugh, M.D.
Signal transduction and pathogenicity of Cryptococcus neoformans
Duke University Medical Center
Approved $210,000   Paid $35,000
Kent L. Buchanan, Ph.D.
Acquired host resistance in cryptococcal meningitis
Tulane University Medical Center
Paid $32,500
Gary M. Cox, M.D.
Antisense repression in Cryptococcus neoformans
Duke University Medical Center
Paid $70,000
Tamara L. Doering, M.D., Ph.D.
Mechanisms of capsule biosynthesis in Cryptococcus neoformans
Washington University School of Medicine
Paid $70,000
Scott G. Filler, M.D.
Stimulation of endothelial cells in Candida albicans
University of California-Los Angeles School of Medicine
Paid $70,000
Gary B. Huffnagle, Ph.D.
Role of melanin production by Cryptococcus neoformans in evasion 
of host defenses
University of Michigan Medical Center
Paid $32,500
Ashraf S. Ibrahim, Ph.D.
Molecular genetics approach for studying the role of iron permease 
in the virulence of Rhizopus oryzae
University of California-Los Angeles School of Medicine
Approved $210,000   Paid $35,000
Patrick J. Keeling, Ph.D.
Early infection and adaptation to intracellular parasitism 
in Microsporidia
University of British Columbia
Paid $70,000
Jennifer K. Lodge, Ph.D.
Identification of virulence-related determinants in Cryptococcus 
neoformans
Saint Louis University School of Medicine
Paid $32,500
Jose L. Lopez-Ribot, Pharm.D., Ph.D.
Gene and protein expression profiling in Candida albicans biofilms
University of Texas Health Science Center-San Antonio
Approved $210,000   Paid $35,000
Neal F. Lue, M.D., Ph.D.
Functional analysis of telomerase components in Candida albicans
Weill Medical College of Cornell University
Paid $70,000
Anita Sil, M.D., Ph.D.
Genetic analysis of pathogenesis in Histoplasma capsulatum
University of California-San Francisco School of Medicine
Paid $70,000
A. George Smulian, M.B., B.Ch.
Role of MAP kinase Mkp1 in the regulation of cell wall synthesis 
in Pneumocystis carinii
University of Cincinnati College of Medicine
Paid $70,000
Brian L. Wickes, Ph.D.
Identification of mating type-associated antifungal targets 
in Cryptococcus neoformans
University of Texas Health Science Center-San Antonio 
Paid $32,500
Jon Woods, M.D., Ph.D.
Antisense regulation of a protein kinase gene in Histoplasma 
capsulatum
University of Wisconsin Medical School
Paid $70,000
SUBTOTALS: Approved  $630,000
Paid  $795,000
New Investigator Awards in Molecular Pathogenic Mycology
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James P. Allen, Ph.D.
Elizabeth Davidson, Ph.D.
Arizona State University
Structure-based design of mosquitocidal toxins
Paid $25,000
Russ B. Altman, M.D., Ph.D.
Stanford University School of Medicine
Knowledge base of biological function for malaria
Paid $100,000
Sailen Barik, Ph.D.
University of South Alabama College of Medicine
Signal transduction in Plasmodium
Paid $25,000
Scott D. Bohle, Ph.D.
University of Wyoming
Peter W. Stephens, Ph.D.
State University New York-Stony Brook 
Interaction of the quinoline antimalarials and malaria pigment
Paid $100,000
Jon C. Clardy, Ph.D.
Cornell University
Inhibitors of dihydroorotate dehydrogenase for malaria treatment
Paid $100,000
Fred E. Cohen, M.D., D.Phil.
University of California-San Francisco
Joseph L. Derisi, Ph.D.
University of California-San Francisco School of Medicine
Functional genomics approach to identification of new antimalarial
drug targets
Approved $400,000   Paid $50,000
John B. Dame, Ph.D.
University of Florida College of Veterinary Medicine
Thomas C. Rowe, Ph.D.
University of Florida College of Medicine 
Discovery of a novel malarial DNA gyrase and its development 
as a drug target
Paid $50,000
Roberto Docampo, M.D., Ph.D.
University of Illinois at Urbana-Champaign College of Veterinary
Medicine 
Acidocalcisomes in Plasmodium
Paid $25,000
David A. Fidock, Ph.D.
William R. Jacobs, Ph.D.
Albert Einstein College of Medicine
Molecular genetic analysis of Plasmodium falciparum
Approved $100,000   Paid $25,000
Partho Ghosh, Ph.D.
University of California-San Diego
Structural studies of Plasmodium falciparum histidine-rich 
protein 2 
Paid $50,000
Daniel L. Hartl, Ph.D.
Harvard University
Dyann F. Wirth, Ph.D.
Harvard School of Public Health 
Why are there so few synonymous single nucleotide polymorphisms
in Plasmodium falciparum
Paid $100,000
Timothy A. J. Haystead, Ph.D.
Duke University Medical Center
Mining the malarial purine-binding proteome for novel drugs 
and their targets
Approved $200,000   Paid $50,000
Christopher A. Hunter, Ph.D.
University of Pennsylvania School of Veterinary Medicine
Role of NFKB in resistance to malaria
Paid $25,000
Anthony A. James, Ph.D.
University of California-Irvine
Genetic control of anopheline vectors
Paid $100,000
Keith A. Joiner, M.D.
Yale University School of Medicine
Mechanism of hemoglobin uptake in malaria
Approved $400,000   Paid $50,000
Kami Kim, M.D.
Vern L. Schramm, Ph.D.
Albert Einstein College of Medicine 
Genetic dissection of purine salvage pathways in Plasmodium
Approved $100,000   Paid $25,000
Walter H. Lewis, Ph.D.
Washington University
Daniel E. Goldberg, M.D., Ph.D.
Washington University School of Medicine 
Optimizing the search for new antimalarial therapeutics
Paid $100,000
New Initiatives in Malaria Research
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Michael A. Marletta, Ph.D.
University of Michigan College of Pharmacy
Heme detoxification in Plasmodium
Paid $50,000
Thomas V. McDonald, M.D.
Albert Einstein College of Medicine
K+ channels as therapeutic targets in malaria
Paid $25,000
Paul D. Roepe, Ph.D.
Georgetown University
James A. Martiney, Ph.D.
Kenneth S. Warren Laboratories 
Single-cell photometric analysis of drug-resistant malaria
Paid $80,000
Stewart H. Shuman, M.D., Ph.D.
Sloan-Kettering Institute
Targeting of mRNA cap formation for treatment of malaria
Approved $100,000   Paid $25,000
Mary M. Stevenson, Ph.D.
Philippe Gros, Ph.D.
McGill University Faculty of Medicine 
Genetic and functional dissection of susceptibility to malaria
Paid $100,000
Akhil B. Vaidya, Ph.D.
MCP Hahnemann University School of Medicine
Plasma membrane proton pumps in malaria parasites
Paid $100,000
Dyann F. Wirth, Ph.D.
Harvard School of Public Health
Plasmodium falciparum transcriptome: analysis of drug response
Paid $50,000
SUBTOTALS: Approved  $1,300,000
Paid  $1,430,000
Other Grants
In addition to making competitive awards, BWF makes noncompetitive grants for activities that are closely related to our major focus areas.
These grants are intended to enhance the general environment for research in the targeted areas.
GENERAL
American Society of Tropical Medicine and Hygiene
Support for a new BWF-ASTMH Fellowship in Tropical Infectious Diseases
Paid $52,000
CDC Foundation
Support for students who participate in the CDC’s Elective Rotation 
in Applied Epidemiology as part of the Epidemic Intelligence Service’s
Fiftieth Anniversary Fellowship Program
Approved $5,000   Paid $5,000
Duke University
Support for the United Kingdom-United States Exchange Program
reunion and review meeting
Approved $20,000
National Academy of Sciences
Support for the Institute of Medicine’s Forum on Emerging Infections
Approved $25,000   Paid $25,000
National Institute of Allergy and Infectious Diseases
Support for a conference titled “Dendritic Cells at the Host-Pathogen
Interface”
Approved $3,000   Paid $3,000
North Carolina Department of Health and Human Services
Support for a project titled “Surveillance and Evaluation of
Environmental Microbiology in the Aftermath of Flooding in Eastern
North Carolina, 1999”
Paid $50,000
University of Cambridge
Support for a “Try-Tryp” meeting
Approved $35,000   Paid $35,000
WHO/TDR
Support for the International Training Course on Bioinformatics
(Computational Biology) Applied to Genomic Studies 
Approved $12,000   Paid $12,000
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MOLECULAR PARASITOLOGY
American Society of Tropical Medicine and Hygiene
Support for the society’s annual meeting
Approved $25,000   Paid $25,000
Cesar Chavez Multicultural Academy
Support for program activities, in lieu of an honorarium for Thomas 
E. Wellems, M.D., Ph.D., a member of the BWF Molecular
Parasitology/Malaria Advisory Committee 
Approved $3,000   Paid $3,000
Fogarty International Center
Support for the third Pan-African conference organized 
by the Multilateral Initiative on Malaria 
Approved $20,000   Paid $20,000
Gordon Research Conferences
Support for the Malaria Gordon Conference
Approved $10,000   Paid $10,000
Harvard School of Public Health
Support for the Harvard Malaria Initiative workshop titled “Genomes
to Drugs” 
Approved $10,000   Paid $10,000
Keystone Symposia
Support for a meeting titled “Molecular Helminthology: An Integrated
Approach” and for a meeting workshop titled “Threat of Drug
Resistance: Strategy Session”
Paid $12,500
Keystone Symposia
Support for Robert Bergquist, Ph.D., of WHO/TDR, to attend the 
symposium titled “Toward the Genetic Manipulation of Insects”
Approved $3,000   Paid $3,000
Keystone Symposia
Support for two symposia: “Malaria’s Challenge: From Infants 
to Genomics to Vaccines” and “Drugs Against Tropical Protozoan
Parasites: Target Selections, Structural Biology, and Rational Medicinal
Chemistry”
Approved $10,000   Paid $10,000
Laval University Faculty of Medicine
Support for two symposia of past and present BWF awardees 
in the molecular parasitology program held at the International
Congress of Parasitology
Approved $10,000   Paid $10,000
Malaria Foundation 
Support for activities to reach the international scientific community
Approved $50,000   Paid $50,000
Marine Biological Laboratory
Support for the training course titled “Biology of Parasitism,” 
from 1999 to 2003 
Paid $150,000
Monash University
Support for creation of an integrated Plasmodium genome database 
Approved $213,372   Paid $69,033
National Institute of Allergy and Infectious Diseases 
Support for the BWF/NIAID/Biology of Parasitic Infection 
lecture series
Approved $5,000   Paid $5,000
Naval Medical Research Center
Support for a meeting on variant proteins expressed on the surface 
of infected erythrocytes and their role in developing malaria vaccines
Approved $7,500   Paid $7,500
Seattle Biomedical Research Institute
Support for travel costs of BWF new investigator Theresa Gaasterland,
Ph.D., to give a seminar at the institute
Approved $1,000   Paid $1,000
Stanford Genome Technology Center
Support for finalizing genome sequencing “gap closure” 
for Plasmodium falciparum chromosome 12
Paid $100,000
University of Georgia
Support for the Center for Tropical and Emerging Global Diseases, 
in lieu of an honorarium for Daniel G. Colley, Ph.D., a member 
of the BWF Molecular Parasitology/Malaria Advisory Committee
Approved $3,000   Paid $3,000
University of Pennsylvania
Support for creation of an integrated Plasmodium genome database 
Paid $254,498
($213,372 of original award to the University of Pennsylvania was
transferred/cancelled)
University of Texas Southwestern Medical Center-Dallas 
Support for a meeting titled “Polyamine Metabolism of Parasitic
Protozoa as a Drug Target”
Approved $2,000   Paid $2,000
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American Society for Microbiology
Support for the sixth annual conference on Candida and candidiasis
Approved $2,500   Paid $2,500
Institute for Genomic Research
Support for a meeting to discuss sequencing the Aspergillis fumigatus
genome 
Approved $7,500   Paid $7,500
Korean Baptist Church
Support for program activities, in lieu of an honorarium for June
Kwon-Chung, Ph.D., a member of the BWF Molecular Pathogenic
Mycology Advisory Committee
Approved $3,000   Paid $3,000
Marine Biological Laboratory
Support for the training course titled “Molecular Mycology: Current
Approaches to Fungal Pathogenesis,” from 2000 to 2002
Paid $85,000
Midwest Microbial Pathogenesis Meeting
Support for the group’s seventh annual meeting
Approved $4,000   Paid $4,000
National Institute of Allergy and Infectious Diseases
Support for U.S. participants at the Medical Mycological Society of Japan’s
second U.S.-Japan meeting focusing on the importance of genome
projects for the medical mycology community
Approved $10,000   Paid $10,000
Saint Louis University School of Medicine
Support for a Cryptococcus neoformans genome meeting
Approved $17,000   Paid $17,000
South Australian Medical Postgraduate Education Association
Support for 10 young investigators to attend the Fifth International
Conference on Cryptococcus and Cryptococcosis
Approved $12,500   Paid $12,500
University of Arizona
Support for scientists to travel to the Twenty-First Fungal Genetics
Conference
Approved $10,000   Paid $10,000
University of British Columbia
Support for a symposium on the evolution of protist parasites, held 
at the International Society for Evolutionary Protistology
Approved $10,000   Paid $10,000
University of Cincinnati College of Medicine
Support for the Seventh International Workshops on Opportunistic
Protists
Approved $5,000   Paid $5,000
University of Virginia Health System
Support for a symposium on the E. histolytica genome project at the
annual American Society of Tropical Medicine and Hygiene meeting 
Approved $8,700   Paid $8,700
SUBTOTALS: Approved  $563,072
Paid  $1,102,731
Transferred/Cancelled  $213,372
Grants Index/Infectious Diseases 
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Cross-Disciplinary Training Program in Biophysical Dynamics
University of Chicago
Stephen J. Kron, M.D., Ph.D.
Norbert F. Scherer, Ph.D.
Approved $2,500,000   Paid $375,000
Graduate Program in Quantitative Biology
University of California-San Francisco School of Pharmacy
David A. Agard, Ph.D.
University of California-San Francisco School of Medicine
Ken A. Dill, Ph.D.
University of California-San Francisco School of Pharmacy
Approved $2,500,000   Paid $375,000
Interdisciplinary Graduate and Postdoctoral Training Program 
in Physics, Chemistry, and Biology
Rockefeller University
Stephen K. Burley, M.D., D.Phil.
Albert Libchaber, Ph.D.
Paid $548,000
Interdisciplinary Training Program in Brain Science
Brown University
John P. Donoghue, Ph.D.
David Mumford, Ph.D.
Paid $460,952
La Jolla Interfaces in Science Training Program
Consortium of the University of California-San Diego, the Scripps
Research Institute, the Salk Institute of Biological Studies, and the 
San Diego Supercomputing Center; grant administered by the
University of California-San Diego
Elizabeth D. Getzoff, Ph.D.
Scripps Research Institute
José N. Onuchic, Ph.D.
University of California-San Diego
Approved $1,000,000   Paid $549,954
Program in Computational Biology
Johns Hopkins University
Michael Paulaitis, Ph.D.
Johns Hopkins University
George D. Rose, Ph.D.
Johns Hopkins University School of Medicine
Paid $500,000
Program in Computational Molecular Biology
California Institute of Technology
Scott E. Fraser, Ph.D.
Michael L. Roukes, Ph.D.
Paid $500,000
Program in Mathematical and Computational Neuroscience
Boston University
Howard B. Eichenbaum, Ph.D.
Nancy J. Kopell, Ph.D.
Approved $1,750,000   Paid $262,500
Program in Mathematics and Molecular Biology
Consortium of 17 laboratories at 12 institutions nationwide; grant
administered by Florida State University
Wilma K. Olson, Ph.D.
Rutgers, the State University of New Jersey-Piscataway
DeWitt L. Sumners, Ph.D.
Florida State University
Approved $1,000,000   Paid $500,000
Training Program in Biological Dynamics
Princeton University
John J. Hopfield, Ph.D.
Simon A. Levin, Ph.D.
Approved $2,500,000   Paid $375,000
SUBTOTALS: Approved  $11,250,000
Paid  $4,446,406
Interfaces in Science
TOTALS: Approved  $11,740,384    Paid  $5,526,373     
Institutional Awards at the Scientific Interface
Listed by name of the training program, the institution or consortium conducting the program, and the researchers directing the program.
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Christopher B. Burge, Ph.D.
Phillip A. Sharp, Ph.D.
Massachusetts Institute of Technology
Whole genome approaches to pre-mRNA splicing specificity 
and regulation
Paid $100,000
Wah Chiu, Ph.D.
Baylor College of Medicine
Gregor Eichele, Ph.D.
Max-Planck Institute for Experimental Endocrinology
Spatial and temporal database of gene expression patterns 
of mouse brain
Paid $68,000
R. Mark Henkelman, Ph.D.
University of Toronto Faculty of Medicine
Eugene Fiume, Ph.D.
University of Toronto
Automated image analysis of genetically modified mice
Paid $100,000
Terence T.-L. Hwa, Ph.D.
University of California-San Diego
Gene expression profiles based on statistical significance of clustering
analysis
Paid $63,250
Monica J. Justice, Ph.D.
John S. Weber, Ph.D.
Baylor College of Medicine
Ian J. Jackson, Ph.D.
Western General Hospital
Mutagenesis of central mouse chromosome 4: a paradigm for functional
analysis of mammalian genomes
Paid $100,000
Sudhir Kumar, Ph.D.
Arizona State University
Computational genomic analysis to identify and dissect functionally
important mutations in protein sequences
Paid $50,000
Elaine A. Ostrander, Ph.D.
Leonid Kruglyak, Ph.D.
University of Washington School of Medicine
Mapping cancer susceptibility genes in dogs by linkage disequilibrium
Paid $100,000
Gene E. Robinson, Ph.D.
University of Illinois at Urbana-Champaign
Sociogenomics: functional genomic analyses of social behavior 
with microarrays
Paid $133,333
Eric D. Siggia, Ph.D.
Frederick R. Cross, Ph.D.
Rockefeller University
Computational and experimental analysis of promoters in the genome
of budding yeast
Paid $25,000
Oliver Smithies, D.Phil.
University of North Carolina-Chapel Hill School of Medicine
Computer simulation and animal modeling of complex genetic systems
Paid $100,000
Alan R. Templeton, Ph.D.
Washington University
Cladistic analyses of epistasis among candidate genes influencing 
common disease
Paid $50,000
SUBTOTALS: Paid  $889,583
Innovation Awards in Functional Genomics
These special one-time-only awards were made in conjunction with the dedication of BWF’s headquarters building in 2000. Future support 
for the field of functional genomics is incorporated into ongoing BWF programs.
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INTERFACES IN SCIENCE
Biophysical Society
Support for the postdoctoral career development session at the 
society’s annual meeting 
Approved $2,500   Paid $2,500
Canadian Genetic Diseases Network
Support for an expansion of the computer-laboratory workshops 
in bioinformatics 
Approved $106,000   Paid $106,000
Florida State University
Support for a meeting titled “Modelling across the Scales” to include
the trainees and mentors from BWF’s 10 Institutional Awards at the
Scientific Interface training programs
Approved $300,000
Marine Biological Laboratory
Support for advertising the course titled “Modeling of Biological
Systems”
Approved $6,884   Paid $6,884
National Academy of Sciences
Support for a workshop on the interface of biomedical science with
the mathematical sciences
Approved $25,000   Paid $25,000
FUNCTIONAL GENOMICS
Institute for Theoretical Physics
Support for a Statistical Physics and Biological Information Program
Approved $50,000   Paid $50,000
SUBTOTALS: Approved  $490,384
Paid  $190,384
Other Grants
In addition to making competitive awards, BWF makes noncompetitive grants for activities that are closely related to our major focus areas.
These grants are intended to enhance the general environment for research in the targeted areas.
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Sunil K. Ahuja, M.D.
HIV-1 AIDS pathogenesis: bridging the gap between host genotype 
and HIV transmission/disease phenotype
University of Texas Health Science Center-San Antonio
Approved $750,000   Paid $75,000
Nina Bhardwaj, M.D., Ph.D.
Vaccination of HIV-1 positive individuals by antigen-pulsed 
dendritic cells
Rockefeller University
Paid $150,000
Cameron S. Carter, M.D.
Multimodal brain imaging and the pharmacotherapy of cognitive 
disability in schizophrenia
University of Pittsburgh School of Medicine
Approved $750,000   Paid $75,000
Gilbert Chu, M.D., Ph.D.
Cancer treatment by genome-wide transcription scanning
Stanford University Medical Center
Paid $150,000
Robert B. Darnell, M.D., Ph.D.
Detection and activation of tumor-specific killer cells in animal 
models and cancer patients
Rockefeller University
Paid $150,000
Claire M. Doerschuk, M.D.
Response of neutrophils during inflammatory lung disease
Case Western Reserve University School of Medicine
Paid $150,000
Robert W. Doms, M.D., Ph.D.
Chemokine receptors as new targets for HIV-1 therapeutics
University of Pennsylvania School of Medicine
Paid $150,000
Jeffrey A. Drebin, M.D., Ph.D.
Targeted suppression of B-catenin in colorectal cancer
Washington University School of Medicine
Approved $750,000   Paid $75,000
Brian J. Druker, M.D.
Mechanism-based therapy for chronic myelogenous leukemia
Oregon Health Sciences University
Paid $150,000
Erol Fikrig, M.D.
Borrelia gene expression and lyme arthritis
Yale University School of Medicine
Paid $150,000
Glenn I. Fishman, M.D.
Gap junction channels as novel anti-arrhythmic targets
Mount Sinai School of Medicine
Approved $750,000   Paid $75,000
Thomas F. Gajewski, M.D., Ph.D.
Development of a second generation melanoma vaccine
University of Chicago Pritzker School of Medicine
Paid $150,000
Lisa M. Guay-Woodford, M.D.
Genetic modifiers in recessive polycystic kidney disease: implications
for pathogenesis and therapeutics
University of Alabama-Birmingham School of Medicine
Approved $750,000  Paid $75,000
Clinical Scientist Awards in Translational Research
During the fiscal year, some award recipients change institutions, modify the terms of their award at their current institution, or both change
institutions and modify their award. In these cases, BWF’s policy has been to cancel the remaining portion of the original award and, as necessary,
approve a new award. When the award recipient has changed institutions, the new award is made to the new institution; when the award recipient
has not moved but has modified the terms, the new award is made to the current institution. In the following descriptions, the name of the award
recipient is listed first, the title of the project is listed second, the award recipient’s current institution is listed third, and the amount approved or
paid to the institution is listed fourth. For award recipients who either changed institutions or modified their award, the portion of the award paid
to the original institution, as well as any portion that was transferred or cancelled, is listed last, in parentheses.
Translational Research
(Encompassing grant programs formerly grouped under the focus area therapeutic sciences)  
TOTALS: Approved  $10,017,700    Paid  $8,202,700
Grants Index/Translational Research
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Eva Guinan, M.D.
Extending the donor pool by inducing alloantigen specific T-cell 
anergy ex vivo for human hematopoietic stem cell transplantation
Harvard Medical School
Paid $150,000
Barbara L. Hempstead, M.D., Ph.D.
Growth factor regulation of coronary angiogenesis
Weill Medical College of Cornell University
Paid $150,000
Marshall S. Horwitz, M.D., Ph.D.
Therapeutic inhibition of aberrant protease activity in inherited 
neutropenias
University of Washington School of Medicine
Approved $750,000   Paid $75,000
Daniel C. Javitt, M.D., Ph.D.
NMDA-based treatment development for schizophrenia
New York University School of Medicine
Paid $150,000
Alex E. MacKenzie, M.D., Ph.D.
Cytoprotective NAIP and XIAP genes: identification of activation 
pathways and inducing agents 
University of Ottawa Faculty of Medicine
Paid $150,000
Joseph M. McCune, M.D., Ph.D.
Regulation of human thymic function in vivo
University of California-San Francisco School of Medicine
Paid $150,000
M. Juliana McElrath, M.D., Ph.D.
Induction of cellular immunity in HIV-1 exposed seronegative 
individuals
University of Washington School of Medicine
Paid $150,000
Elizabeth M. McNally, M.D., Ph.D.
Microvascular spasm in the progression of cardiomyopathy
University of Chicago
Approved $750,000   Paid $75,000
Jason D. Morrow, M.D.
Isoprostanes as markers and mediators of oxidant stress in humans
Vanderbilt University Medical Center
Paid $150,000
Anthony J. Muslin, M.D.
Signaling mechanisms in cardiovascular disease
Washington University School of Medicine
Approved $750,000   Paid $75,000
Mark R. Philips, M.D.
Endomembrane trafficking of Ras: novel molecular targets for 
anticancer agents
New York University School of Medicine
Paid $150,000
Steven A. Porcelli, M.D.
Defining the protective human CD8+ T-cell response against
Mycobacterium tuberculosis
Albert Einstein College of Medicine
Approved $750,000   Paid $75,000
Daniel J. Rader, M.D.
Novel therapeutic approach to atherosclerosis through modulation 
of HDL metabolism
University of Pennsylvania School of Medicine
Paid $150,000
W. Edward Robinson Jr., M.D., Ph.D.
Structure-function analyses of clinically relevant HIV integrases
University of California-Irvine College of Medicine
Paid $150,000
Don C. Rockey, M.D.
Cellular and molecular basis of portal hypertension: 
an endothelialopathy in cirrhosis
Duke University Medical Center
Paid $150,000
Howard A. Rockman, M.D.
Novel molecular therapeutic strategies in heart failure: 
role of beta-adrenergic receptor desensitization
Duke University Medical Center
Paid $150,000
Antony Rosen, M.B., Ch.B.
Altered structure and clearance of autoantigens during apoptosis:
implications for autoimmunity
Johns Hopkins University School of Medicine
Paid $150,000
Marc E. Rothenberg, M.D., Ph.D.
Experimental analysis of eosinophil-associated gastrointestinal 
inflammation
University of Cincinnati College of Medicine
Approved $750,000   Paid $75,000
54
Grants Index/Translational Research
New Investigator Awards in the Pharmacological or Toxicological Sciences
Christian W. Schindler, M.D., Ph.D.
Intervention of IL-5 signaling: a therapeutic paradigm for asthma
Columbia University College of Physicians and Surgeons
Paid $150,000
Ann Marie Schmidt, M.D.
Novel therapeutic strategy for the prevention and treatment of diabetic
complications: antagonism of receptor for advanced glycation end
products (RAGE)
Columbia University College of Physicians and Surgeons
Paid $150,000
Mark H. Siegelman, M.D., Ph.D.
Functionally activated lymphocyte CD44 in the initiation and 
perpetuation of autoimmune disease
University of Texas Southwestern Medical Center-Dallas
Paid $150,000
Joyce M. Slingerland, M.D., Ph.D.
Resistance to tamoxifen: a consequence of altered p27Kip1 regulation
during breast cancer progression  
University of Toronto Faculty of Medicine
Paid $150,000
Dennis J. Templeton, M.D., Ph.D.
Stress signaling inhibitors potentiate genotoxin-induced apoptosis 
in a human colon tumor model
Case Western Reserve University School of Medicine
Paid $150,000
Matthew L. Warman, M.D.
Delineating the proteins and pathways that maintain human joints
and their potential for treating heritable and acquired forms of arthritis
Case Western Reserve University School of Medicine
Paid $150,000
Mark J. Yeager, M.D., Ph.D.
Structure and function of cardiac gap junction membrane channels
Scripps Research Institute
Paid $150,000
Hagop Youssoufian, M.D.
Transcellular gene therapy: application to Fanconi anemia
Baylor College of Medicine
Paid $150,000
SUBTOTALS: Approved  $7,500,000
Paid  $5,100,000
PHARMACOLOGICAL SCIENCES
Lee S. Bardwell, Ph.D.
Novel roles for protein-protein interactions in mitogen-activated 
protein kinase signaling
University of California-Irvine
Paid $70,000
Peter J. Belshaw, Ph.D.
Combinatorial synthesis of non-ribosomal peptide-based electrophilic
libraries
University of Wisconsin-Madison
Approved $210,000   Paid $35,000
Anton M. Bennett, Ph.D.
p21Ras signaling by protein tyrosine dephosphorylation
Yale University School of Medicine
Approved $210,000   Paid $35,000
Charles M. Brenner, Ph.D.
Genomic approach to identify chemotherapeutic targets
Thomas Jefferson University Jefferson Medical College 
Paid $32,500
Kathleen Collins, Ph.D.
Biochemical and structural characterization of recombinant
Tetrahymena telomerase
University of California-Berkeley
Paid $32,500
Graeme W. Davis, Ph.D.
Molecular and genetic analysis of synaptic homeostasis
University of California-San Francisco School of Medicine
Paid $70,000
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Pehr A. B. Harbury, Ph.D.
DNA display: in vitro evolution of small molecules
Stanford University School of Medicine
Paid $70,000
Bruce A. Hay, Ph.D.
Identification and characterization of regulators of caspase-dependent
cell death signaling
California Institute of Technology
Paid $32,500
Neil L. Kelleher, Ph.D.
Genome-proteome correlations in respiratory pathogens: an experimental
approach for identification of new pharmacological targets
University of Illinois at Urbana-Champaign
Paid $70,000
Kerry Kornfeld, M.D., Ph.D.
Sar-5, a novel negative regulator of Ras signaling
Washington University School of Medicine
Paid $32,500
Calvin J. Kuo, M.D., Ph.D.
Physiologic and pathologic roles of vascular endothelial growth factor 
Stanford University School of Medicine
Approved $210,000   Paid $35,000
Andres V. Maricq, M.D., Ph.D.
Dominant activation of neurons: a genetic approach to uncover 
mechanisms of neuronal signaling and control of behavior
University of Utah
Paid $70,000
Carla Mattos, Ph.D.
Surface features of the Ral GTPase obtained from the multiple solvent
crystal structures and from its complex with RalBP1 and calmodulin
North Carolina State University
Paid $70,000
Rama Ranganathan, M.D., Ph.D.
Assembly and function of multi-protein complexes in visual signaling
University of Texas Southwestern Medical Center-Dallas
Paid $32,500
Ram Sasisekharan, Ph.D.
Heparin-like glycosaminoglycans as a target for therapeutic intervention
Massachusetts Institute of Technology
Paid $70,000
David P. Siderovski, Ph.D.
GoLoco motif-derived peptides as selective G-protein “perturbagens”
University of North Carolina-Chapel Hill School of Medicine
Approved $210,000   Paid $35,000
Scott K. Silverman, Ph.D.
Phototriggered folding approaches to RNA structural motifs and 
RNA-protein interactions
University of Illinois at Urbana-Champaign
Approved $210,000   Paid $35,000
Erik J. Sontheimer, Ph.D.
Reversible control of RNA structure with small biarsenical ligands
Northwestern University
Paid $70,000
Natalie C. Strynadka, Ph.D.
Antibiotic discovery targeting essential proteins on the bacterial 
outer membrane
University of British Columbia Faculty of Medicine
Paid $70,000
Joseph Tsien, Ph.D.
Novel pharmacogenetic approach to neuronal signaling
Princeton University
Paid $70,000
Wilfred A. van der Donk, Ph.D.
Exploring the post-translational modifications of lantibiotics
University of Illinois at Urbana-Champaign
Paid $32,500
Lu-Yang Wang, Ph.D.
Regulation of synaptic strength by subtype-specific coupling between
Ca2+ channels and metatropic receptors
University of Toronto Faculty of Medicine
Approved $210,000  Paid $35,000
Beverly R. Wendland, Ph.D.
New pathways to the cell interior: dominant negative and positive
effectors of endocytosis
Johns Hopkins University
Paid $70,000
Hongtao Yu, Ph.D.
Molecular investigation of transitions and checkpoints in mitosis
University of Texas Southwestern Medical Center-Dallas
Paid $70,000
Grants Index/Translational Research
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TOXICOLOGICAL SCIENCES
Raffi V. Aroian, Ph.D.
Bacillus thuringiensis toxicity and resistance in nematodes
University of California-San Diego
Paid $70,000
Karlene A. Cimprich, Ph.D.
Exploring DNA damage checkpoints using a cell-free system
Stanford University School of Medicine
Paid $70,000
Philip A. Cole, M.D., Ph.D.
Chemical cross-linking agents for identification of substrates 
for protein kinases
Johns Hopkins University School of Medicine
Paid $32,500
Virginia W. Cornish, Ph.D.
In vivo screening for enzymatic activity
Columbia University
Paid $70,000
Mohanish P. Deshmukh, Ph.D.
Caspase activation during apoptosis: a novel mechanism of regulation
in neurons
University of North Carolina-Chapel Hill School of Medicine
Approved $210,000   Paid $35,000
Bevin P. Engelward, Sc.D.
Fluorescent detection of loss heterozygosity in mammals
Massachusetts Institute of Technology
Paid $70,000
James M. Ford, M.D.
Transcriptional regulation of damage-inducible DNA repair genes
Stanford University School of Medicine
Paid $70,000
Hilary A. Godwin, Ph.D.
Biophysical approaches to lead toxicology: biochemistry, detection,
and chelation of Pb(II)
Northwestern University
Paid $32,500
Su Guo, Ph.D.
Mechanism of action of neurotoxins that induce parkinsonism: 
a molecular genetic study in zebra fish
University of California-San Francisco School of Pharmacy
Approved $210,000   Paid $35,000
Carla M. Koehler, Ph.D.
Mitochondrial biogenesis in health and disease: assembly of the 
mitochondrial inner membrane
University of California-Los Angeles
Paid $70,000
Fang Liu, Ph.D.
Role of transforming growth factor-beta-inducible gene regulation 
in tumorigenesis
Rutgers, the State University of New Jersey College of Pharmacy
Paid $70,000
Anna K. Mapp, Ph.D.
Small molecules for reprogramming gene expression
University of Michigan College of Pharmacy
Approved $210,000   Paid $35,000
Thomas W. Muir, Ph.D.
Structure-activity analysis of the autoinducing peptides from
Staphylococcus aureus responsible for virulence
Rockefeller University
Paid $70,000
Tomas A. Prolla, Ph.D.
Genetic characterization of the DNA mismatch repair system 
in induced mutagenesis
University of Wisconsin Medical School
Paid $70,000
Terry L. Sheppard, Ph.D.
Chemical toxicology of oxidative DNA damage lesions
Northwestern University
Approved $210,000   Paid $35,000
Grants Index/Translational Research
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Christopher Bradfield, Ph.D.
Molecular genetic approaches to study dioxin toxicology
University of Wisconsin-Madison
Paid $60,000
Titia de Lange, Ph.D.
Cell-based assays for telomerase toxicity
Rockefeller University
Paid $80,000
SUBTOTALS: Paid  $140,000
Other Grants
Scholar Awards in Experimental Therapeutics
This program was superceded by the Clinical Scientist Awards in Translational Research program.
Scholar Awards in Toxicology
This program was superceded by the New Investigator Awards in the Pharmacological or Toxicological Sciences programs.
Arturo Casadevall, M.D., Ph.D.
Development of novel antibody-based drugs against bacterial 
and fungal pathogens
Albert Einstein College of Medicine
Paid $60,000
Jonathan D. Gitlin, M.D.
Mechanisms of cellular copper homeostasis
Washington University School of Medicine
Paid $80,000
Daniel L. Kaufman, Ph.D.
Biopharmaceuticals for the prevention of insulin-dependent 
diabetes mellitus
University of California-Los Angeles School of Medicine
Paid $80,000
Thomas Michel, M.D., Ph.D.
Nitric oxide synthases and vascular signal transduction
Harvard Medical School
Paid $60,000
SUBTOTALS: Paid  $280,000
Zhigang Wang, Ph.D.
Mechanism of DNA damage-induced mutagenesis in humans
University of Kentucky
Paid $32,500
Zhengui Xia, Ph.D.
Mechanisms of arsenite neurotoxicity
University of Washington School of Public Health and Community
Medicine
Paid $70,000
E. Lynn Zechiedrich, Ph.D.
DNA repair and topoisomerases
Baylor College of Medicine
Paid $32,500
SUBTOTALS: Approved  $2,100,000
Paid  $2,215,000
Grants Index/Translational Research
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TRANSLATIONAL RESEARCH
American Federation for Medical Research
Support for trainees to attend the federation’s annual meeting
Approved $10,000   Paid $10,000
American Society for Clinical Investigation/American Association 
of Physicians
Support for the joint meeting of the society and the association
Approved $10,000   Paid $10,000
Association of American Medical Colleges
Support for the development of the Association for the Accreditation
of Human Research Protection Programs
Approved $200,000   Paid $200,000
Clinical Research Alliance
Support for a meeting titled “Clinical Research 2001” 
Approved $75,000   Paid $75,000
National Academy of Sciences
Support for the Institute of Medicine’s Clinical Research Roundtable
Paid $50,000
PHARMACOLOGICAL OR TOXICOLOGICAL SCIENCES
American Society for Pharmacology and Experimental Therapeutics
Support for a symposium and associated plenary speaker at the
Experimental Biology 2001 meeting 
Approved $10,000   Paid $10,000
Aspen Cancer Conference
Support for young investigators to attend a conference titled
“Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and
Cancer Therapy”
Approved $3,000   Paid $3,000
Baylor College of Medicine
Support for laboratory clean up due to damage from Tropical Storm
Allison
Approved $15,000   Paid $15,000
Cold Spring Harbor Laboratory
Support for a meeting to examine how pharmacogenomics and 
diagnostics will intersect
Approved $10,000   Paid $10,000
McGill University
Support for the Second International Meeting on Male-Mediated
Developmental Toxicity
Approved $5,000   Paid $5,000
Society of Toxicology
Support for a program to introduce undergraduates to the field of 
toxicology and for travel awards associated with the society’s annual
meeting
Approved $10,000   Paid $10,000
Society of Toxicology of Canada
Support for the society’s annual symposium
Approved $6,700   Paid $6,700
Stanford University
Support for a conference on DNA repair
Approved $10,000   Paid $10,000
Teratology Society
Support for the society’s annual meeting
Approved $5,000   Paid $5,000
GENERAL 
International Conference on the Chemistry and Biology 
of Mineralized Tissues
Support for two new investigators to travel to the Sixth International
Conference on the Chemistry and Biology of Mineralized Tissues
Approved $3,000   Paid $3,000
North Carolina Biotechnology Center
Support for the North Carolina Genomics and Bioinformatics
Consortium
Approved $45,000   Paid $45,000
SUBTOTALS: Approved  $417,700
Paid  $467,700
In addition to making competitive awards, BWF makes noncompetitive grants for activities that are closely related to our major focus areas.
These grants are intended to enhance the general environment for research in the targeted areas.
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American Chemical Society, North Carolina Local Section
Summer Educational Experience for the Disadvantaged
Approved $179,779   Paid $59,979
Bennett College
Mathematics, Science, Engineering, and Technology Scholars Program
Paid $60,000
Campbell University School of Pharmacy
Harnett Central Middle School Science and Technology Enrichment
Program
Approved $109,800   Paid $42,850
Catawba Science Center
Science Technology Enrichment Program
Approved $113,280   Paid $36,300
Cumberland County Schools 
Cape Fear Natural Science Academy
Paid $60,000
Duke University
Design to Learn
Paid $23,532
Duke University
Techtronics: Hands-on Exploration of Technology in Everyday Life
Approved $167,500   Paid $47,500
Duke University Nicholas School of the Environment and Earth
Sciences
Connecting Coastal Communities
Approved $84,659   Paid $28,053
Durham Academy
Durham Public Schools Summer Institute
Paid $60,000
Johnson C. Smith University
Intensive Summer Science Camp
Paid $58,897
Lenoir-Rhyne College
Carolina Institute for the Multicultural Approach to Science
Approved $179,995   Paid $60,000
Mountain Area Gardens in Community
Middle School Apprenticeship Program in Garden-Related Sciences
($24,403 of original award was transferred/cancelled)
North Carolina Museum of Life and Science
Museums and Universities for Science Enrichment of Students
Paid $60,724
North Carolina State Museum of Natural Science
Girls in Science Statewide Project
Paid $54,975
North Carolina State University
Performing Inquiry Based Exploration
Approved $66,600   Paid $22,200
North Carolina State University
Science and Mathematics Colloquies at the Science House
Paid $58,311
Onslow Community Ministries
Sturgeon City Student Science Series
Approved $51,693   Paid $51,693
Pines of Carolina Girl Scout Council
Healthy START-UP:  Science and Technology around Research 
Triangle Park
Paid $60,000
Roanoke Rapids City Schools
Summer Science Explorations in the Roanoke Valley
Paid $20,000
Shaw University
Mentoring and Encouraging the Science Skills of Youth
Paid $60,000
Shodor Education Foundation 
Stimulating Understanding of Computational Science through
Collaboration, Experiment, and Discovery
Paid $58,596
Swain County Schools
Students Involved and Experiencing Nature, Careers in Science, 
and Environmental Awareness
Paid $26,673
Science Education
TOTALS:   Approved  $1,451,353    Paid  $2,244,216    Transferred/Cancelled  $24,403
Student Science Enrichment Program
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BWF Visiting Professorships in the Basic Medical Sciences
Listed by host institution, visiting professor, and professor’s affiliation. Titles of BWF Lectures cited if given in fiscal year 2001.
University of North Carolina-Chapel Hill School of Medicine
Scientific Enrichment Opportunities for High School Students
Approved $179,730   Paid $59,910
University of North Carolina-Wilmington
Oceanographic field support for Summer Ventures in Science and
Mathematics
Paid $10,125
Warren Wilson College
Environmental Science Camp
Paid $48,750
Wilmington Children’s Museum
Middle School Docent Program
Paid $6,000
SUBTOTALS: Approved  $1,133,036
Paid  $1,135,068
Transferred/Cancelled  $24,403
Grants Index/Science Education
Albert Einstein College of Medicine
Jack L. Strominger, M.D.
Harvard University
Paid $5,000
Baylor College of Medicine
Richard A. Crowther, Ph.D.
Medical Research Council (United Kingdom) 
Approved $5,000
Baylor College of Medicine
Carl H. June, M.D.
University of Pennsylvania School of Medicine
Adoptive immunotherapy: long-term memories and therapeutic 
vaccines for lymphoma
Paid $5,000
Case Western Reserve University School of Medicine
Susan S. Taylor, Ph.D.
University of California-San Diego
Approved $5,000
Central Caribbean University School of Medicine
Anatoli Lopatin, Ph.D.
University of Michigan-Ann Arbor
Approved $5,000
Creighton University School of Medicine
William E. Paul, M.D.
National Institute of Allergy and Infectious Diseases
Cytokine biology
Paid $5,000
Dalhousie University Faculty of Medicine
Victor Ling, Ph.D.
University of British Columbia Faculty of Medicine
Approved $5,000
East Carolina University School of Medicine
David A. Williams, M.D.
Indiana University School of Medicine
Approved $5,000
Harvard Medical School
Mitchell Kronenberg, Ph.D.
La Jolla Institute of Allergy and Immunology
Approved $5,000
Indiana University-Bloomington
Jill Bargonetti, Ph.D.
Hunter College
Tumor suppression by a central controller called p53
Paid $5,000
Iowa State University
Helmut Sies, M.D., Ph.D.
University of Dusseldorf (Germany)
Approved $5,000
Iowa State University
J. G. Sutcliffe, Ph.D.
Scripps Research Institute
Using total gene expression analysis; gene expression profiling to
investigate neuropsychiatric disorders and neuromodulatory peptides
for sleeping, dreaming, and eating
Paid $5,000
Louisiana State University Health Sciences Center
Miles D. Houslay, Ph.D.
University of Glasgow (United Kingdom)
Viral immune evasion
Paid $5,000
Loyola University of Chicago Stritch School of Medicine
Hidde L. Ploegh, Ph.D.
Harvard Medical School
Paid $5,000
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Marshall University School of Medicine
Daria Mochly-Rosen, Ph.D.
Stanford University School of Medicine
Localization inhibitors in signal transduction: what we dream of,
nature dreamt before
Paid $5,000
McGill University Faculty of Medicine
Gerard Karsenty, M.D., Ph.D.
Baylor College of Medicine
Approved $5,000
McGill University Faculty of Medicine
Salvador Moncada, M.D., Ph.D. 
University College London (United Kingdom)
Nitric oxide and cell respiration: physiology and pathophysiology
Paid $5,000
Medical College of Wisconsin
Donald A. Fischman, M.D.
Weill Medical College of Cornell University
Approved $5,000
Medical University of South Carolina College of Medicine
Aravinda Chakravarti, Ph.D.
Johns Hopkins University School of Medicine
Approved $5,000
Memorial University of Newfoundland Faculty of Medicine
Stephen W. Scherer, Ph.D.
Hospital for Sick Children in Toronto
Approved $5,000
Morehouse School of Medicine
Alan A. Jackson, M.B., B.Chir., M.D.
University of Southampton (United Kingdom)
Approved $5,000
Morehouse School of Medicine
Stephen C. Strom, Ph.D.
University of Pittsburgh
Use of hepatocytes in basic and clinical studies
Paid $5,000
New York University School of Medicine
Jose M. C. Ribeiro, M.D., Ph.D.
National Institute of Allergy and Infectious Diseases
Approved $5,000
North Dakota State University
Adrianne Bendich, Ph.D.
SmithKline Beecham Consumer Health Care
Supplements: role in improving health in the 21st century
Paid $5,000
North Dakota State University College of Pharmacy
Maret G. Traber, Ph.D.
Oregon State University
Approved $5,000
Oregon State University College of Pharmacy
Frances M. Ashcroft, Ph.D., Sc.D.
University Laboratory of Physiology (United Kingdom)
Approved $5,000
Pennsylvania State University College of Medicine
Alphonse E. Sirica, Ph.D.
Virginia Commonwealth University
Biliary cancer: molecular pathogenesis to new therapeutic strategies
Paid $5,000
Purdue University School of Pharmacy and Pharmaceutical Sciences
William A. Catterall, Ph.D.
University of Washington School of Medicine
Approved $5,000
Rutgers, the State University of New Jersey-Piscataway
Eric Westhof, Ph.D.
University Louis Pasteur (France) 
Approved $5,000
Saint Francis Xavier University
John W. Hanrahan, Ph.D.
McGill University
Approved $5,000
Saint Louis University School of Medicine
Ronald C. Conaway, Ph.D.
Oklahoma Medical Research Foundation
Approved $5,000
State University of New York Upstate Medical Center-Syracuse
Mikhail Ugryumov, M.D., Ph.D.
Russian Academy of Sciences (Russia)
Neurotransplantation in treatment of neurodegenerative diseases
Paid $5,000
Texas A&M University College of Veterinary Medicine
Elaine A. Ostrander, Ph.D.
Fred Hutchinson Cancer Research Center
Approved $5,000
Tulane University School of Medicine
Edward B. Ziff, Ph.D.
New York University
Trafficking of AMPA receptors and the regulation of excitatory synapses
Paid $5,000
Grants Index/Science Education
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University of Arizona College of Medicine
Susan L. Lindquist, Ph.D.
University of Chicago
From mad cows to “psi-chotic” yeast: new frontiers in genetics, disease,
and materials science
Paid $5,000
University of Calgary Faculty of Medicine
Edward E. Harlow, Ph.D.
Harvard Medical School
Paid $5,000
University of California-Berkeley
James Barber, Ph.D.
Imperial College of Science, Technology, and Medicine (United Kingdom)
Where does the oxygen we breathe come from?
Paid $5,000
University of California-Davis
Frederic M. Richards, Ph.D.
Yale University
Paid $5,000
University of California-Los Angeles School of Medicine
Michael A. Farrell, M.B., B.Chir.
Royal College of Surgeons (Republic of Ireland)
Approved $5,000
University of California-San Francisco School of Medicine
Shirley M. Tilghman, Ph.D.
Princeton University
Epigenetic regulation of mammalian growth and development
Paid $5,000
University of Colorado-Boulder
Xiao-dong Wang, Ph.D.
University of Texas Southwestern Medical Center-Dallas
Approved $5,000
University of Georgia
Charles J. Billington, M.D.
Minneapolis Veterans Affairs Medical Center
Approved $5,000
University of Guelph
John C. Herr, Ph.D.
University of Virginia Health Sciences Center
From basic sperm biology to commercialization of a diagnostic device:
biotechnology underlying Sperm Check I, an immunochromatographic
card for detecting low numbers of sperm
Paid $5,000
University of Miami School of Medicine
Irving L. Weissman, M.D.
Stanford University School of Medicine
Approved $5,000
University of Michigan-Dearborn
Ralph M. Garruto, Ph.D.
State University of New York-Binghamton
Approved $5,000
University of Minnesota
Tony Hunter, Ph.D.
Salk Institute for Biological Studies 
Cell signaling through tyrosine phosphorylation
Paid $5,000
University of Minnesota-Duluth School of Medicine
Dean P. Jones, Ph.D.
Emory University School of Medicine
Approved $5,000
University of Mississippi Medical Center
Charles F. Stevens, M.D., Ph.D.
Salk Institute for Biological Studies
Paid $5,000
University of Missouri-Columbia School of Medicine
Ian A. Wilson, D.Phil.
Scripps Research Institute
Paid $5,000
University of Missouri-Kansas City School of Medicine
Ralph Snyderman, M.D.
Duke University Medical Center
Enhancing clinical research: a key to improving health in the 
United States
Paid $5,000
University of Montreal Faculty of Medicine
John G. R. Jefferys, Ph.D.
University of Birmingham (United Kingdom)
Neuronal networks for oscillations and epilepsy and neuronal 
mechanisms of transition to seizures
Paid $5,000
University of North Carolina-Chapel Hill School of Pharmacy
Tamar Schlick, Ph.D.
New York University
A trajectory of DNA from applied to basic research
Paid $5,000
University of North Carolina-Chapel Hill School of Public Health
Barbara B. Kahn, M.D.
Harvard Medical School
Approved $5,000
University of Pittsburgh School of Medicine
Angela M. Gronenborn, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases
Molecular structures: important clues for understanding biology
Paid $5,000
Grants Index/Science Education
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BWF Visiting Professorships in the Microbiological Sciences
Listed by host institution, visiting professor, and professor’s affiliation. Titles of BWF lectures cited if given in fiscal year 2001.
University of South Dakota School of Medicine
John E. Hall, Ph.D.
University of Mississippi Medical Center
Role of neuropeptides and the sympathetic nervous system in obesity
hypertension
Paid $5,000
University of Texas Medical Branch-Galveston
Jan-Ake Gustafsson, M.D., Ph.D.
Karolinska Institute (Sweden)
Approved $5,000
University of Vermont College of Medicine
Pier M. Mannucci, M.D.
University of Milan (Italy)
Progress and problems in congenital coagulation disorders
Paid $5,000
University of Washington School of Medicine
Leslie A. Leinwand, Ph.D.
University of Colorado-Boulder
Approved $5,000
University of Western Ontario Faculty of Medicine and Dentistry
John E. Walker, D.Phil.
Medical Research Council (United Kingdom)
Approved $5,000
University of Wisconsin School of Medicine
Arturo Casadevall, M.D., Ph.D.
Albert Einstein College of Medicine
Approved $5,000
Virginia Commonwealth University
Can Ince, M.D.
University of Amsterdam (Netherlands)
Paid $5,000
Washington State University College of Pharmacy
Lawrence A. Loeb, M.D., Ph.D.
University of Washington School of Medicine
Approved $5,000
Wayne State University School of Medicine
Anthony T. Campagnoni, Ph.D.
University of California-Los Angeles
Problem in reverse genetics: finding an alternative function for myelin
basic protein gene
Paid $5,000
West Virginia University School of Pharmacy
James R. Halpert, Ph.D.
University of Texas Medical Branch-Galveston
Structure-function relationships of mammalian drug-metabolizing
cytochrome P450
Paid $5,000
Wright State University School of Medicine
Debra I. Diz, Ph.D.
Wake Forest University School of Medicine
Approved $5,000
SUBTOTALS: Approved  $165,000
Paid  $160,000
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Chaminade University of Honolulu
John M. Besser, Ph.D.
Minnesota Department of Health
Public health care in the former Soviet Union
Paid $5,000
Davidson College
Raul J. Cano, Ph.D.
California Polytechnic State University
Approved $5,000
Florida International University
Nicholas Cohen, Ph.D.
University of Rochester School of Medicine and Dentistry
Approved $5,000
Florida International University
Michael A. Zasloff, M.D., Ph.D.
Magainin Research Institute
Paid $5,000
Georgia Southern University
Bettina Wilske, Ph.D.
Max von Pettenkofer Institute for Hygiene and Medicinal Microbiology
(Germany)
Lyme borreliosis: causative agent, epidemiology, and clinical picture
Paid $5,000
Goucher College
Lynn Margulis, Ph.D.
University of Massachusetts
Approved $5,000
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Lehman College
Roberto Docampo, M.D., Ph.D.
University of Illinois at Urbana-Champaign College of Veterinary
Medicine
Trypanosomal acidocalcisomes
Paid $5,000
Louisiana State University
Bonnie L. Bassler, Ph.D.
Princeton University
Approved $5,000
McMaster University
Jens Boman, M.D.
University Hospital of Umea (Sweden)
The role of Chlamydia pneumoniae in respiratory disease
Paid $5,000
Morehouse School of Medicine
Anthony S. Fauci, M.D.
National Institute of Allergy and Infectious Diseases
Approved $5,000
North Carolina Central University
Stuart M. Brown, Ph.D.
New York University Medical Center
Approved $5,000
Northern Arizona University
Erik de Clercq, M.D., Ph.D.
University of Leuven Medical School (Belgium)
Chemotherapy of human immunodeficiency virus infection
Paid $5,000
Oakland University
Timothy J. Donohue, Ph.D.
University of Wisconsin-Madison
Approved $5,000
Oklahoma State University
James M. Tiedje, Ph.D.
Michigan State University
Getting a grip on microbial diversity
Paid $5,000
University of Central Arkansas
Thomas M. Terry, Ph.D.
University of Connecticut
Paid $5,000
University of Guam
William Fenical, Ph.D.
University of California-San Diego
Approved $5,000
University of Guelph
Geoffrey M. Gadd, Ph.D.
University of Dundee (United Kingdom)
Approved $5,000
University of Missouri-Rolla
Kenneth H. Nealson, Ph.D.
California Institute of Technology
The search for life in the universe: lessons from the Earth
Paid $5,000
University of Puerto Rico-Humacao University College
Mindy Brashears, Ph.D.
University of Nebraska-Lincoln
Current issues in hazard analysis and critical control point
Paid $5,000
University of Tennessee-Knoxville
Harald von Boehmer, M.D., Ph.D., D.Sc.
Dana-Farber Cancer Institute
Paid $5,000
University of Texas-El Paso
Joseph O. Falkinham III, Ph.D.
Virginia Polytechnic Institute and State University
Approved $5,000
Wayne State University School of Medicine
Randall K. Holmes, M.D., Ph.D.
University of Colorado Health Sciences Center
Approved $5,000
SUBTOTALS: Approved  $55,000
Paid  $55,000
Grants Index/Science Education
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Alzheimer’s Association
Support for programs, in lieu of an honorarium for Elmima Johnson,
Ph.D., a member of the SSEP Advisory Committee
Approved $1,250   Paid $1,250
American Heart Association
Support for programs, in lieu of an honorarium for Elmima Johnson,
Ph.D., a member of the SSEP Advisory Committee
Approved $1,250   Paid $1,250
American Society for Microbiology
Support for administering the BWF Visiting Professorships in the
Microbiological Sciences
Approved $2,500   Paid $2,500
American Society for Microbiology
Support for the annual Biomedical Research Conference for Minority
Students
Approved $5,000   Paid $5,000
Canadian Federation of Biological Societies
Support for administering the BWF Visiting Professorships in the Basic
Medical Sciences
Approved $2,500   Paid $5,000
Durham Public Education Network
Support for general activities
Approved $500   Paid $500
Durham Public Education Network
Support for a one-year pilot science education project
Approved $17,000   Paid $17,000
Federation of American Societies for Experimental Biology
Support for administering the BWF Visiting Professorships in the Basic
Medical Sciences
Approved $11,317   Paid $11,317
Grantmakers for Education
Support for general activities
Approved $3,000   Paid $3,000
Medical Research Council of Canada
Support for the BWF Student Research Award Program 
Paid $500,000
National Academy of Sciences
Support for a workshop on issues and opportunities for Ph.D. 
scientists who are interested in becoming high school teachers
Paid $100,000
National Association of Academies of Science
Support for a session at the annual meeting of the American
Association for the Advancement of Science to provide high school
students an opportunity to interact with scientists
Approved $2,500   Paid $2,500
North Carolina Biotechnology Center
Support for the Student National Medical Association’s clinical
research symposium and a health and career awareness fair for middle
school and high school students and their parents
Approved $2,500   Paid $2,500
North Carolina Center for International Understanding
Support for four teachers to participate in the center’s Math/Science
Exchange and Study Program
Approved $8,000   Paid $8,000
North Carolina FFA Foundation
Support for the foundation’s Agriscience Fair
Approved $500   Paid $500
North Carolina Society of Hispanic Professionals
Support for the Hispanic Educational Summit 2001
Approved $500   Paid $500
North Carolina State University
Support for a series of conferences of representatives from university
science departments to discuss K-12 outreach
Paid $90,431
Public School Forum of North Carolina
Support for developing an international study program for educational
policymakers
Paid $47,900
Public School Forum of North Carolina
Support for the Institute for Educational Policymakers
Paid $75,000
Shodor Education Foundation 
Support for developing and maintaining the Student Science
Enrichment Program Web site
Approved $15,000   Paid $15,000
University of North Carolina-Chapel Hill
Support for developing the Center for Functional Nanostructures
Approved $25,000   Paid $5,000
SUBTOTALS: Approved  $98,317
Paid  $894,148 
Grants Index/Science Education
Other Grants
In addition to making competitive awards, BWF makes noncompetitive grants for activities that are closely related to our major focus areas.
These grants are intended to enhance the general environment for research in the targeted areas.
American Society for Cell Biology
Support for the society’s annual meeting 
Approved $3,600   Paid $3,600
American Society for Clinical Nutrition
Support for the National Clinical Nutrition Internships program
Approved $6,000   Paid $6,000
American Society for Nutritional Sciences
Support for a new graduate education initiative
Approved $11,000   Paid $11,000
Council on Foundations
Support for general activities
Approved $39,600   Paid $39,600
Foundation Center
Support for general activities
Approved $7,500   Paid $7,500
Foundation for the National Institutes of Health
Support for the tenth anniversary symposium of the Office of Research
on Women’s Health 
Approved $2,500   Paid $2,500
Grantmakers in Health
Support for general activities
Approved $5,000   Paid $5,000
National Institute of Environmental Health Sciences 
Support for a biomedical science career fair
Approved $3,600   Paid $3,600
National Library of Medicine
Support for general activities
Approved $5,000   Paid $5,000
North Carolina Association for Biomedical Research
Support for general activities
Approved $25,000   Paid $25,000
North Carolina Center for Nonprofits
Support for a conference commemorating the center’s tenth anniversary
Approved $13,500   Paid $13,500
Sigma Xi, the Scientific Research Society
Support for a conference titled “Science, the Arts, and the Humanities:
Connections and Collisions”
Approved $10,000   Paid $10,000
Southeastern Council of Foundations
Support for general activities
Approved $5,000   Paid $5,000
University of North Carolina-Chapel Hill School of Pharmacy
Support for the development of the Institute of Natural Medicine
Approved $25,000   Paid $25,000
SUBTOTALS: Approved  $162,300
Paid  $162,300
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Science and Philanthropy
TOTALS:   Approved  $240,800    Paid  $400,800    
General 
Communications
American Association for the Advancement of Science
Support for the Mass Media Science and Engineering Fellows Program
Approved $16,000   Paid $16,000
Council for the Advancement of Science Writing
Support for the New Horizons in Science Briefing and the Traveling
Fellowship Program 
Approved $30,000   Paid $30,000
SUBTOTALS: Approved  $46,000
Paid  $46,000
Wellcome Trust
Support for the Wellcome Trust’s tour of the exhibit titled “The
Phantom Museum”
Approved $15,000
SUBTOTALS: Approved  $15,000
Grants Index/Science and Philanthropy
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Science Policy
History of Medicine
American Association for the Advancement of Science
Support for the Center for Science, Technology, and Congress
Paid $100,000
Association of Academic Health Centers
Support for the annual fall meeting, titled “Exploring the Nexus of
Research and Business: the Balanced Solutions for Academic Health
Centers”
Approved $7,500   Paid $7,500
Center for the Advancement of Health
Support for translating research into policy and practice
Paid $50,000
Research!America
Support for a project to advocate increased funding for medical
research
Paid $25,000
Society for Women’s Health Research
Support for the dissemination of an Institute of Medicine report on
sex-based biology
Approved $10,000   Paid $10,000
SUBTOTALS: Approved  $17,500
Paid  $192,500
The Burroughs Wellcome Fund makes approximately 90 percent of our grants through competitive award programs, which support investigators
in targeted areas of basic scientific research that have relevance to human health. Most of BWF’s award programs are open only to citizens or
permanent residents of the United States and Canada. (Programs with different requirements are noted in the descriptions that follow.) Awards
are made with the advice of our advisory committees, which comprise scientists and educators selected for their expertise in the program areas.
Program application deadlines for the 2003 award series are listed in the “Program Application Deadlines” section on page 71.
Most grants are made only to degree-granting institutions on behalf of individual researchers, who must be nominated by their institution.
Institutions receiving grants must be tax-exempt 501(c)(3) organizations. Government agencies, such as the National Institutes of Health and
the Centers for Disease Control and Prevention, generally are not eligible for grants.
Throughout the following program descriptions, references to M.D. and Ph.D. degrees include all types of medical and scientific doctoral degrees.
BWF believes that diversity within the scientific community enhances the well-being of the research enterprise; therefore, we encourage applications
from women and from members of underrepresented minority groups.
BWF does not support activities that are primarily clinical in nature (such as disease diagnosis and treatment) or primarily related to health care
and health care policy. We generally do not provide support for research projects or other activities outside our competitive programs, nor do we
generally support endowments, development campaigns, ordinary operating expenses, capital facilities and equipment, or publications.
To obtain the most up-to-date information about our award programs, visit our Web site at www.bwfund.org
BURROUGHS WELLCOME FUND
Telephone (919) 991-5100
Fax (919) 991-5160
www.bwfund.org
Mailing Address:
Post Office Box 13901
Research Triangle Park, NC  27709-3901
Shipping Address:
21 T. W. Alexander Drive
Research Triangle Park, NC  27709
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Career Awards in the Biomedical Sciences
These awards are made in honor of Gertrude B. Elion, D.Sc., and
George H. Hitchings, Ph.D., who shared the 1988 Nobel Prize in
Physiology or Medicine and were long associated with the Burroughs
Wellcome Fund. The awards are intended to foster the development and
productivity of biomedical researchers who are early in their careers
and to help them make the critical transition to becoming independent
investigators. The grants provide $500,000 over five years to bridge
advanced postdoctoral training and the first three years of faculty service.
Recipients may spend part of the grant period at institutions in the
United Kingdom. BWF expects to award about 20 of these grants
annually. Approximately half of the awards will go to researchers with
a Ph.D. degree and half to those with an M.D. or M.D.-Ph.D. degree.
Candidates must have completed at least 12 months but not more
than 48 months of postdoctoral research training by the application
deadline. For candidates with M.D. degrees, postdoctoral training
excludes clinically oriented residencies that do not contain a major
research component. Researchers who hold a faculty appointment as
an assistant professor or the equivalent, or who know they will hold
such an appointment within a year of the application deadline, are
not eligible.
Infectious Diseases
Investigators in Pathogenesis of Infectious Disease
These awards provide new opportunities for accomplished investigators
at the assistant professor level to study pathogenesis, with a focus on
the intersection of human and pathogen biology. The program is intended
to shed light on the overarching issues of how human hosts handle
infectious challenge. These five-year grants, which provide $80,000
per year, are intended to give recipients the freedom and flexibility 
to pursue new avenues of inquiry and higher-risk research projects that
hold potential for advancing significantly the biochemical, pharmacological,
immunological, and molecular biological understanding of how infectious
agents and the human body interact. BWF is particularly interested in
work focused on the host, as well as host-pathogen studies originating
in viral, bacterial, fungal, or parasite systems. Studies in these areas may
have their root in the pathogen, but the focus of the work should be
on the effects on the host at the cellular and/or systemic levels. Excellent
animal models of human disease are within the scope of the program.
Candidates must have an established record of independent research
and hold a tenure-track position as an assistant professor or equivalent
at a degree-granting institution in the United States or Canada. Up to
nine of these grants will be awarded. 
Interfaces in Science
Career Awards at the Scientific Interface
These awards are intended to foster the early career development of
researchers with backgrounds in the physical/computational sciences
whose work addresses biological questions and who are dedicated to
pursuing a career in academic research. Candidates are expected to draw
from their training in a scientific field other than biology to propose
innovative approaches to answer important questions in the biological
sciences. The grants provide up to $500,000 over five years to support
up to two years of advanced postdoctoral training and the first three
years of a faculty appointment. BWF expects to award up to eight of
these grants in 2003. Candidates must have a Ph.D. degree in physics,
chemistry (physical, theoretical, or computational), mathematics,
computer science, statistics, or engineering. Exceptions will be made
only if the candidate can demonstrate significant expertise in one of these
areas, evidenced by publications or advanced course work. In addition
to being open to U.S. and Canadian citizens and permanent residents,
this program is open to temporary residents whose lawful immigration
status has been granted and will extend for the duration of the award. 
Institutional Awards at the Scientific Interface
These grants, which are made to degree-granting institutions, are intended
to encourage the interdisciplinary training of graduate and postdoctoral
students from the physical, chemical, and computational sciences so
they can better apply their unique knowledge and talents to biological
problems. BWF has made grants in this program in 1996, 1998, and
2000. We expect to commit up to $10 million for these grants each year
they are offered, and the grants will provide from $150,000 to $500,000
per year for up to five years. Emphasis will be placed on supporting
new programs or existing programs that will change graduate and
postdoctoral training in a meaningful way, as opposed to programs seeking
more funding for activities already under way. Specific guidelines may
change for future awards, which will not be made until at least 2004.
Competitive Award Programs
Basic Biomedical Sciences
Information for Applicants
Translational Research
Clinical Scientist Awards in Translational Research
These awards are intended to foster the development and productivity 
of established independent physician-scientists who will strengthen
translational research, the two-way transfer between work at the 
laboratory bench and clinical medicine. The grants provide $750,000
over five years ($150,000 per year). BWF expects to award up to 10 
of these grants annually. We are interested particularly in supporting
investigators who will bring novel ideas and new approaches to trans-
lational research and who will mentor the next generation of physician-
scientists. Proposed activities may draw on the many recent advances
in the basic biomedical sciences—including such fields as biochemistry,
cell biology, genetics, immunology, molecular biology, and pharmacology
—that provide a wealth of opportunities for studying and alleviating
human disease. Candidates generally must be affiliated with a medical
school; candidates at other types of degree-granting institutions (including
schools of veterinary medicine, public health, and pharmacy) will be
considered only if they can demonstrate a plan for coordinating with
institutions that provide the patient connection essential for translational
research. Candidates must have an M.D. or M.D.-Ph.D. degree and
hold an appointment or joint appointment in a subspecialty of clinical
medicine. In exceptional circumstances, non-M.D. candidates will be
considered if their work is likely to contribute significantly to the clinical
enterprise; these candidates should hold an appointment or joint
appointment in a clinical department. Candidates must be tenure-track
investigators at the late assistant professor level or the associate professor
level, or hold an equivalent tenure-track position, at the time of appli-
cation. Candidates must present evidence of already having established
an independent research career, as this is not a “new investigator” award.
Individuals holding the rank of professor are ineligible.
Science Education
Student Science Enrichment Program
These awards are limited to nonprofit organizations in BWF’s home
state of North Carolina. BWF provides $1 million annually for this
program, and grants provide up to $60,000 per year for three years.
The program’s goals include improving students’ competence in science,
nurturing their enthusiasm for science, and interesting them in pursuing
careers in research or other science-related areas. The awards are
intended to support projects that provide creative science enrichment
activities for students in the sixth through twelfth grades who have
shown exceptional skills and interest in science, as well as those 
who may not have had an opportunity to demonstrate conventional
“giftedness” in science but are perceived to have high potential. The
projects must enable students to participate in hands-on scientific
activities and pursue inquiry-based avenues of exploration—an 
educational approach that has proven to be an effective way to increase
students’ understanding and appreciation of the scientific process. 
Project activities must take place outside of the usual school environment,
such as after school, on weekends, or during vacation periods. Projects
may be conducted all year, during the school year, or during the summer.
Eligible organizations include colleges and universities, community
groups, museums and zoos, public and private schools, scientific
groups, and others that can provide experiential activities for middle
school and high school students. We encourage partnerships—for
example, between scientific groups and school systems or between
universities and community groups. Industries may participate in 
collaboration with nonprofit organizations that assume the lead role.
Science and Philanthropy
BWF makes noncompetitive grants for activities that fall outside of our
competitive award programs but are closely related to our targeted
areas, such as career development of scientists or the pathogenesis 
of infectious disease. We place special priority on working with non-
profit organizations, including government agencies, to leverage financial
support for our targeted areas of research, and on encouraging other
foundations to support biomedical research. Proposals should be 
submitted to BWF in the form of a letter, which should be no more
than five pages. Applicants should describe the focus of the activity,
the expected outcomes, and the qualifications of the organization 
or individuals involved; provide certification of the sponsor’s Internal
Revenue Service tax-exempt status; and give the total budget for the
activity, including any financial support obtained or promised. Proposals
are given careful preliminary review, and those deemed appropriate
are presented for consideration by BWF’s Board of Directors.
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BASIC BIOMEDICAL SCIENCES
Career Awards in the Biomedical Sciences October 1, 2002
INFECTIOUS DISEASES
Investigators in Pathogenesis of Infectious Disease November 1, 2002
INTERFACES IN SCIENCE
Career Awards at the Scientific Interface May 1, 2002
Institutional Awards at the Scientific Interface See note below*
TRANSLATIONAL RESEARCH
Clinical Scientist Awards in Translational Research September 1, 2002
SCIENCE EDUCATION
Student Science Enrichment Program April 10, 2002
SCIENCE AND PHILANTHROPY Received all year
* These institutional awards are offered periodically, alternating with Career Awards at the Scientific Interface.  
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PROGRAM APPLICATION DEADLINES
2003 Award Series
Career Awards in the Biomedical Sciences
Mina J. Bissell, Ph.D.
Ernest Orlando Lawrence Berkeley National Laboratory
Pamela J. Bjorkman, Ph.D.
Howard Hughes Medical Institute
California Institute of Technology
William Chin, M.D.
Eli Lilly and Company
Patricia K. Donahoe, M.D.
Massachusetts General Hospital
Harvard Medical School
Elaine Fuchs, Ph.D.
Howard Hughes Medical Institute
University of Chicago
Phil Gold, M.D., Ph.D.
Montreal General Hospital
McGill University Faculty of Medicine
Thomas M. Jessell, Ph.D.
Columbia University
Lawrence C. Katz, Ph.D.
Howard Hughes Medical Institute
Duke University Medical Center
Stanley J. Korsmeyer, M.D.
Howard Hughes Medical Institute
Dana-Farber Cancer Institute
Harvard Medical School
George M. Langford, Ph.D.
Dartmouth College
Martin M. Matzuk, M.D., Ph.D.
Baylor College of Medicine
Suzanne R. Pfeffer, Ph.D. (Cochair)
Stanford University School of Medicine
John F. Sheridan, Ph.D.
Ohio State University
Jerome F. Strauss III, M.D., Ph.D. (Cochair)
University of Pennsylvania Health System
Ian A. Wilson, D.Phil.
Scripps Research Institute
James M. Wilson, M.D., Ph.D.
Institute for Human Gene Therapy
University of Pennsylvania Health System
Christopher Wylie, Ph.D.
University of Cincinnati College of Medicine
72
ADVISORY COMMITTEES
The Burroughs Wellcome Fund uses advisory committees for each competitive award program to review grant applications and make recommendations
to BWF’s Board of Directors, which makes the final decisions. We select members of these committees for their scientific and educational expertise 
in the program areas. In addition, BWF uses a financial advisory committee to help in developing and reviewing the Fund’s investment policies.
This committee is appointed by and reports to the Board of Directors.
Investigators in Pathogenesis of Infectious Disease
Arturo Casadevall, M.D., Ph.D.
Albert Einstein College of Medicine
Mary K. Estes, Ph.D.
Baylor College of Medicine
Stephen L. Hajduk, Ph.D.
University of Alabama-Birmingham School of Medicine
Philippa Marrack, Ph.D.
Howard Hughes Medical Institute
National Jewish Medical and Research Center
Magdalene So, Ph.D.
Oregon Health Sciences University
P. Frederick Sparling, M.D. (Chair)
University of North Carolina-Chapel Hill School of Medicine
Advisory Commmittees
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Interfaces in Science
Clinical Scientist Awards in Translational Research
Robert H. Austin, Ph.D.
Princeton University
Carlos Bustamante, Ph.D.
Howard Hughes Medical Institute
University of California-Berkeley
Susan N. Coppersmith, Ph.D. 
University of Wisconsin-Madison 
Jeffrey I. Gordon, M.D. (Chair)
Washington University School of Medicine
Douglas A. Lauffenburger, Ph.D.
Massachusetts Institute of Technology
Michael C. Reed, Ph.D.
Duke University
Susan S. Taylor, Ph.D.
Howard Hughes Medical Institute
University of California-San Diego School of Medicine
Martin J. Blaser, M.D. (Cochair)
New York University Medical Center
Bruce A. Chabner, M.D. 
Massachusetts General Hospital
Susan George, M.D.
University of Toronto Faculty of Medicine
John W. Griffin, M.D.
Johns Hopkins University School of Medicine
Alan Krensky, M.D.
Stanford University Medical Center
John E. Niederhuber, M.D.
University of Wisconsin Medical School
Jennifer M. Puck, M.D. (Cochair)
National Human Genome Research Institute
National Institutes of Health
Marlene Rabinovitch, M.D.
University of Toronto Faculty of Medicine
University of Toronto Hospital for Sick Children
Judith L. Swain, M.D.
Stanford University Medical Center
Craig B. Thompson, M.D.
Leonard and Madlyn Abramson Family Cancer Research Institute
University of Pennsylvania Medical Center
Michael J. Welsh, M.D.
Howard Hughes Medical Institute
University of Iowa College of Medicine
Wayne M. Yokoyama, M.D.
Howard Hughes Medical Institute
Washington University School of Medicine
Stephen D. Corman (Chair)
BWF Board of Directors
Michael Even
Citigroup
Ronald Frashure
Acadian Asset Management
W. Curtis Livingston
Western Asset Management
Walter Niemasik
Snyder Capital Management
Philip R. Tracy
BWF Board of Directors
Advisory Commmittees
PHARMACOLOGICAL SCIENCES SUBCOMMITTEE
Lorraine J. Gudas, Ph.D.
Weill Medical College of Cornell University
T. Kendall Harden, Ph.D.
University of North Carolina-Chapel Hill School of Medicine
Lee E. Limbird, Ph.D. (Chair)
Vanderbilt University Medical Center
Victor Ling, Ph.D.
British Columbia Cancer Research Centre
Palmer Taylor, Ph.D.
University of California-San Diego School of Medicine
Jeffrey M. Trent, Ph.D.
National Human Genome Research Institute
National Institutes of Health
TOXICOLOGICAL SCIENCES SUBCOMMITTEE
Barbara F. Hales, Ph.D.
McGill University Faculty of Medicine
Philip Hanawalt, Ph.D.
Stanford University
Victor A. Levin, M.D.
University of Texas M. D. Anderson Cancer Center
Baldomero M. Olivera, Ph.D.
University of Utah
Stephen H. Safe, D.Phil.
Texas A&M University College of Veterinary Medicine
Thomas J. Slaga, Ph.D. (Chair)
AMC Cancer Research Center
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New Investigator Awards in the Pharmacological or Toxicological Sciences
This program is being discontinued after the 2001 award series; however the advisory committees will continue to monitor awardees’ progress.
Student Science Enrichment Program
John E. Burris, Ph.D. (Cochair)
Beloit College
Luciano Corazza, Ph.D.
University of California-San Diego
G. Thomas Houlihan, Ph.D.
Council of Chief State School Officers
Samuel Houston, Ed.D.
Edgate.com
Marian Johnson-Thompson, Ph.D.
National Institute of Environmental Health Sciences
Shirley M. Malcom, Ph.D. (Cochair)
American Association for the Advancement of Science
Sally G. Shuler
Smithsonian Institution
Liz Woolard
W. G. Enloe High School
Investment Committee
The committee is composed of four members from outside BWF and two members from BWF’s Board of Directors. The board’s chair, 
BWF’s president, and BWF’s vice president for finance also serve on the committee as nonvoting members.
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BOARD OF DIRECTORS
Enriqueta C. Bond, Ph.D.
President
Burroughs Wellcome Fund
Gail H. Cassell, Ph.D.
Vice President, Infectious Diseases
Drug Discovery Research and Clinical Investigation
Eli Lilly and Company, Lilly Research Laboratories
Stephen D. Corman
Founder and former Chair and Chief Executive Officer 
PharmaLink Inc.
Henry G. Friesen, M.D.
Distinguished Professor Emeritus, Senior Fellow
Center for the Advancement of Medicine
University of Manitoba
Chair of the Board, Genome of Canada
Albert James Hudspeth, M.D., Ph.D.
Investigator, Howard Hughes Medical Institute
F. M. Kirby Professor and Head, Laboratory of Sensory Neuroscience
Rockefeller University
Board of Directors
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David M. Kipnis, M.D. (Chair)
Distinguished University Professor of Medicine
Washington University School of Medicine
I. George Miller, M.D.
John F. Enders Professor of Pediatric Infectious Diseases
Professor of Epidemiology and Molecular Biophysics and Biochemistry
Yale University School of Medicine
Mary-Lou Pardue, Ph.D.
Boris Magasanik Professor of Biology
Massachusetts Institute of Technology
Philip R. Tracy
Of Counsel
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.
Jean D. Wilson, M.D.
Charles Cameron Sprague Distinguished Professor of Biomedical Science
University of Texas Southwestern Medical Center-Dallas
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LEFT TO RIGHT: 
Enriqueta C. Bond, Ph.D., President
Scott G. Schoedler, Vice President, Finance
Bernadette M. Marriott, Ph.D., Vice President, Programs and Communications
Executive
STAFF
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Staff
SITTING, LEFT TO RIGHT: 
Jennifer Williams, Accountant
Kenneth P. Browndorf, Senior Asset and Accounting Manager
Martie H. Gregory, Senior Manager, Facility and Administrative Services
Judy McConnell, Librarian/Secretary
STANDING, LEFT TO RIGHT: 
Wendell E. Jones, Technology Coordinator
Betsy Stewart, Secretary
Sam Caraballo, Systems and Web Engineer
Glenda H. Oxendine, Document/Web Specialist
Brent Epps, Administrative Support
Catherine L. Voron, Meeting Professional
Barbara J. Evans, Administrative Meeting Assistant
Administration, Finance, Meetings, and Technology
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Staff
SITTING, LEFT TO RIGHT: 
Jean A. Kramarik, Program Associate
D. Carr Agyapong, Senior Program and Communications Officer
Karyn Hede, Communications Officer
Nancy S. Sung, Ph.D., Program Officer
STANDING, LEFT TO RIGHT:
Rolly L. Simpson Jr., Program Associate
Victoria P. McGovern, Ph.D., Program Officer
Debra A. Linkous, Program Associate
Debra J. Jinwright, Administrative Program Assistant
Melanie B. Scott, Program and Database Specialist
Martin Ionescu-Pioggia, Ph.D., Senior Program Officer
Programs and Communications
Staff E-mail Addresses and Focus Areas
ALL PROGRAM AREAS, UNIVERSITY RELATIONS
Bernadette Marriott, Ph.D., bmarriott@bwfund.org
Vice president, programs and communications
BASIC BIOMEDICAL SCIENCES
Martin Ionescu-Pioggia, Ph.D., mionescu@bwfund.org
Senior program officer
Rolly L. Simpson Jr., rsimpson@bwfund.org
Program associate
INFECTIOUS DISEASES
Victoria P. McGovern, Ph.D., vmcgovern@bwfund.org
Program officer
Jean A. Kramarik, jkramarik@bwfund.org
Program associate
INTERFACES IN SCIENCE; TRANSLATIONAL RESEARCH
Nancy S. Sung, Ph.D., nsung@bwfund.org
Program officer
Debra A. Linkous, dlinkous@bwfund.org
Program associate
SCIENCE EDUCATION
D. Carr Agyapong, cagyapong@bwfund.org
Senior program and communications officer
Melanie B. Scott, mscott@bwfund.org
Program and database specialist
To Obtain Information About Programs
BURROUGHS WELLCOME FUND
The most up-to-date information about our programs, including 
complete application information, can be found on our Web site 
at www.bwfund.org
Telephone (919) 991-5100
Fax (919) 991-5160
Mailing Address:
Post Office Box 13901
Research Triangle Park, NC  27709-3901
Shipping Address:
21 T. W. Alexander Drive
Research Triangle Park, NC  27709
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CONTACT INFORMATION FOR MAJOR PROGRAMS
